0001185185-17-001071.txt : 20170510 0001185185-17-001071.hdr.sgml : 20170510 20170510151307 ACCESSION NUMBER: 0001185185-17-001071 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170510 DATE AS OF CHANGE: 20170510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERITYRE CORP CENTRAL INDEX KEY: 0000945828 STANDARD INDUSTRIAL CLASSIFICATION: TIRES AND INNER TUBES [3011] IRS NUMBER: 870535207 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-50053 FILM NUMBER: 17829905 BUSINESS ADDRESS: STREET 1: 1501 INDUSTRIAL ROAD CITY: BOULDER CITY STATE: NV ZIP: 89005 BUSINESS PHONE: 7022931930 MAIL ADDRESS: STREET 1: 1501 INDUSTRIAL ROAD CITY: BOULDER CITY STATE: NV ZIP: 89005 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN TIRE CORP DATE OF NAME CHANGE: 19951117 10-Q 1 amty-20170331.htm INLINE XBRL DOCUMENT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 

 
FORM 10-Q
 

 
(Mark One)
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:   March 31, 2017

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________________ to ____________________.
 
Commission file number: 000-50053
AMERITYRE CORPORATION
(Exact name of small business issuer as specified in its charter)

NEVADA
87-0535207
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)

1501 INDUSTRIAL ROAD, BOULDER CITY, NEVADA
89005
(Address of principal executive offices)
(Zip Code)

(702) 293-1930
(Issuer’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes    No
  
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer        Accelerated filer        Non-accelerated filer        Smaller reporting company

Emerging Growth Companies

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes    No 
 
The number of shares outstanding of Registrant’s Common Stock as of May 10, 2017: 42,647,868 

TABLE OF CONTENTS

 
 
Page
PART I
Item 1.
3
Item 2.
11
Item 3.
19
Item 4.
19
PART II
Item 1.
20
Item 1A.
20
Item 2.
20
Item 3.
20
Item 4.
20
Item 5.
20
Item 6.
20
 
 
 
21
 
 
 
 
PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS
AMERITYRE CORPORATION
Balance Sheets
 
 
 
March 31, 2017
   
June 30, 2016
 
 
 
(Unaudited)
       
ASSETS
           
CURRENT ASSETS
           
Cash
 
$
510,807
   
$
267,302
 
Accounts receivable
   
259,378
     
293,358
 
Inventory - net
   
547,194
     
614,895
 
Prepaid and other current assets
   
129,761
     
103,803
 
Total Current Assets
   
1,447,140
     
1,279,358
 
 
               
PROPERTY AND EQUIPMENT
               
Leasehold improvements
   
196,223
     
153,543
 
Molds and models
   
577,549
     
577,549
 
Equipment
   
2,988,844
     
2,960,246
 
Furniture and fixtures
   
74,921
     
74,921
 
Construction in progress
   
49,732
     
10,198
 
Software
   
305,924
     
305,924
 
Less - accumulated depreciation
   
(3,906,635
)
   
(3,849,937
)
Total Property and Equipment
   
286,558
     
232,444
 
 
               
OTHER ASSETS
               
Patents and trademarks - net
   
154,906
     
175,379
 
Non-current inventory
   
194,066
     
180,050
 
Deposits
   
11,000
     
11,000
 
Total Other Assets
   
359,972
     
366,429
 
TOTAL ASSETS
 
$
2,093,670
   
$
1,878,231
 
 
               
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
CURRENT LIABILITIES
               
Accounts payable and accrued expenses
 
$
473,752
   
$
348,499
 
Current portion of long-term debt
   
19,141
     
20,518
 
Current portion of lease liability
   
7,285
     
6,249
 
Total Current Liabilities
   
500,178
     
375,266
 
 
               
Long-term debt
   
129,111
     
100,142
 
Long-term lease liability
   
2,792
     
8,394
 
TOTAL LIABILITIES
   
632,081
     
483,802
 
 
               
STOCKHOLDERS’ EQUITY
               
Preferred stock: 5,000,000 shares authorized
of $0.001 par value, 2,000,000 shares issued and
outstanding, respectively
   
2,000
     
2,000
 
Common stock: 75,000,000 shares authorized of
$0.001 par value, 42,647,868 and 42,175,287 shares
Issued and outstanding, respectively
   
42,647
     
42,175
 
Additional paid-in capital
   
62,604,245
     
62,579,558
 
Stock payable
   
5,047
     
4,500
 
Accumulated deficit
   
(61,192,350
)
   
(61,233,804
)
Total Stockholders’ Equity
   
1,461,589
     
1,394,429
 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
 
$
2,093,670
   
$
1,878,231
 

The accompanying notes are an integral part of these financial statements.

AMERITYRE CORPORATION
Statements of Operations
(Unaudited)
 
 
 
For the Three Months Ended
March 31,
   
For the Nine Months Ended
March 31,
 
 
 
2017
   
2016
   
2017
   
2016
 
 
                       
NET SALES
 
$
1,133,610
   
$
936,612
   
$
2,849,370
   
$
2,865,433
 
 
                               
COST OF GOODS SOLD
   
693,500
     
618,366
     
1,861,288
     
2,081,813
 
 
                               
GROSS PROFIT
   
440,110
     
318,246
     
988,082
     
783,620
 
 
                               
EXPENSES
                               
Research and development
   
54,130
     
56,839
     
163,174
     
166,406
 
Sales and marketing
   
65,000
     
53,639
     
191,191
     
219,898
 
General and administrative
   
170,813
     
172,270
     
510,596
     
666,910
 
 
                               
Total Expenses
   
289,943
     
282,748
     
864,961
     
1,053,214
 
 
                               
INCOME (LOSS) FROM OPERATIONS
   
150,167
     
35,498
     
123,121
     
(269,594
)
 
                               
OTHER INCOME/(EXPENSE)
                               
Interest expense
   
(1,773
)
   
(870
)
   
(6,837
)
   
(2,404
)
Interest income
   
70
     
28
     
170
     
137
 
Total Other Income/(Expense)
   
(1,703
)
   
(842
)
   
(6,667
)
   
(2,267
)
 
                               
NET INCOME (LOSS)
   
148,464
     
34,656
     
116,454
     
(271,861
)
 
                               
Preferred Stock Dividend
   
(25,000
)
   
(25,000
)
   
(75,000
)
   
(75,000
)
 
                               
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS
 
$
123,464
   
$
9,656
   
$
41,454
   
$
(346,861
)
 
                               
BASIC AND DILUTED INCOME (LOSS) PER SHARE
 
$
0.00
   
$
0.00
   
$
0.00
   
$
(0.01
)
 
                               
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING
   
42,382,635
     
41,951,935
     
42,336,460
     
41,770,978
 
 
The accompanying notes are an integral part of these financial statements.


AMERITYRE CORPORATION
Statements of Cash Flows
(Unaudited)
 
 
 
For the Nine Months Ended
March 31,
 
 
 
2017
   
2016
 
CASH FLOWS FROM OPERATING ACTIVITIES
           
Net income (loss)
 
$
116,454
   
$
(271,861
)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
               
Depreciation and amortization expense
   
77,171
     
116,338
 
Change in allowance for bad debt (recovery)
   
-
     
(289
)
Stock based compensation related to consultant, employee and director options
   
20,706
     
56,238
 
Changes in operating assets and liabilities:
               
Accounts receivable
   
33,980
     
(165,609
)
Inventory and inventory reserve
   
53,685
     
25,318
 
Prepaid and other current assets
   
(83,951
)
   
(38,339
)
Accounts payable and accrued expenses
   
55,253
     
5,731
 
Net Cash Provided (Used) by Operating Activities
   
273,298
     
(272,473
)
CASH FLOWS FROM INVESTING ACTIVITIES
               
Purchase of property and equipment
   
(15,187
)
   
-
 
Net Cash Used by Investing Activities
   
(15,187
)
   
-
 
CASH FLOWS FROM FINANCING ACTIVITIES
               
Payments on lease liability
   
(4,566
)
   
(3,322
)
Payments on notes payable
   
(10,040
)
   
(1,603
)
Preferred stock dividends
   
-
     
(75,000
)
Net Cash Used by Financing Activities
   
(14,606
)
   
(79,925
)
NET INCREASE (DECREASE) IN CASH
   
243,505
     
(352,398
)
CASH AT BEGINNING OF PERIOD
   
267,302
     
455,717
 
CASH AT END OF PERIOD
 
$
510,807
   
$
103,319
 
 
SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES
           
 
           
Interest paid
 
$
6,837
   
$
2,404
 
Income taxes paid
 
$
-
   
$
-
 
 
               
NON-CASH INVESTING AND FINANCING ACTIVITIES
               
 
               
Capitalized lease
 
$
-
   
$
19,337
 
Reclassification of accounts receivable – related party to accounts receivable
 
$
-
   
$
6,312
 
Equipment purchase accrued for, not paid in cash
 
$
-
   
$
7,641
 
Write off of previously reserved forklift tires
 
$
81,224
   
$
-
 
Purchase of fixed assets through debt
 
$
95,625
   
$
-
 
Accrued preferred stock dividends
 
$
75,000
   
$
-
 
Issuance of stock for stock payable
 
$
4,500
   
$
-
 
Issuance of stock for accrued expense
 
$
5,000
   
$
-
 

 
The accompanying notes are an integral part of these financial statements.


AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
March 31, 2017
 
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION
 
The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  We believe the disclosures and information presented are adequate to make the information not misleading.  These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K.  Operating results for the nine months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2017.
 
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K, except as noted below.

Reclassifications

Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements to conform to the current presentation, specifically the separation of “store” inventory as part of other current assets at March 31, 2016.
 
Basic and Fully Diluted Net Loss Per Share
 
Basic and Fully Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period.
 
Our outstanding stock options and warrants have been excluded from the basic and fully diluted net income per share calculation.  We excluded 4,280,000 and 4,300,000 common stock equivalents for the quarters ended March 31, 2017 and 2016, respectively, because they are anti-dilutive with strike prices above market value at period end.
 
Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Issued

In August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (consensus of Emerging Issues Task Force)”.  This Accounting Standards Update addresses the following eight specific cash flow issues: Debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies (COLIs) (including bank-owned life insurance policies (BOLIs)); distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle. ASU 2016-15 amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. For all other public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period.  The Company is currently assessing the impact, if any, to the Company’s financial statements.


AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
March 31, 2017
 
NOTE 3 - INVENTORY

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.
 
 
 
March 31, 2017
   
June 30, 2016
 
 
 
(Unaudited)
       
Raw Materials
 
$
216,436
   
$
257,260
 
Finished Goods
   
570,441
     
663,666
 
Inventory reserve
   
(45,617
)
   
(125,981
)
Inventory - net
 
$
741,260
     
794,945
 
 
Our inventory reserve reflects items that were deemed to be defective or obsolete based on an analysis of all inventories on hand.

In fiscal years 2017 and 2016, the Company critically reviewed all slow moving inventory to determine if defective or obsolete.  If not defective or obsolete we presented these items as non-current inventory because all inventory is ready and available for sale at any moment.  

For those items that are spare maintenance materials or parts kept on hand as backup components of major production equipment, or “store inventories”, the Company capitalizes the amount if above our capitalization policy for property and equipment.  In the past the Company included these items as part of its raw materials inventory.  As of March 31, 2016 these items, amounting to $10,815, have been reclassified into other current assets. 
 
NOTE 4 - DEBT

A former board member, Silas O. Kines, who passed away on January 11, 2012, was also the principal owner of Forklift Tire of Florida and K-2 Industrial Tire, Inc.  In accordance with the Commission Agreement with Forklift Tire of Florida, dated February 2, 2011, between Amerityre Corporation and K-2 Industrial Tire, Inc., K-2 is due a five percent (5%) commission on all forklift tire sales.  In exchange for the forklift models transferred to Amerityre under that agreement, the first $96,000 in commission payments will be used to extinguish the long term liability recorded on the transaction.  As of March 31, 2017, $2,000 and $63,133 (June 30, 2016, $11,752 and $53,840) were recorded for the current and long-term portion, respectively, of the related liability.

In June 2016, the Company executed a term note with U.S. Bank to finance critical manufacturing equipment and operating enhancements.  Manufacturing equipment of approximately $29,000 was placed into service in July 2016.  The remaining operating enhancements are expected to be in service at the end of fiscal 2017.  Total amount financed was $55,068, at 5.59% interest, with payments of $1,059 due for 60 months starting July 2016.

In July 2016, the Company executed a term note with U.S. Bank to finance critical plant facility equipment which was placed into service in July 2016.  The total amount financed was $37,666 at 5.59% interest, with payments of $720 due for 60 months starting October 2016.
 
Payments due by period
 
   
Total
   
Less than
1 year
   
1 to 3 years
   
3 to 5 years
   
After
5 years
 
                               
Bank debt (both US Bank facilities above)
 
$
83,119
   
$
17,141
   
$
59,726
   
$
6,252
   
$
-
 
 
                                       
Total cash obligations
 
$
83,119
   
$
17,141
   
$
59,726
   
$
6,252
   
$
-
 


AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
March 31, 2017

NOTE 5 - CAPITAL LEASE

In July 2015, the Company entered into a capital lease for research and development equipment for $19,337.

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of March 31, 2017:

2017
 
$
2,174
 
2018
   
8,697
 
2019
   
725
 
2020
   
-
 
2021
   
-
 
Total minimum lease payments
   
11,596
 
Less:  executory costs
   
-
 
Net minimum lease payments
   
11,596
 
Less:  amount representing interest
   
(1,533
)
Present value of net minimum payments
 
$
10,063
 

NOTE 6 - STOCK OPTIONS AND WARRANTS

Prior Issuances of options

On December 1, 2015, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2016 and expire December 1, 2020.  

On January 19, 2016, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the Board term ending December 2016.  The options have a strike price of $0.10, vest at the end of the Board term in December 2016 and expire December 2019.  

On January 19, 2016, 50,000 options were granted to the Company’s Chief Financial Officer as part of renewal of her employment agreement.  The options have a strike price of $0.10, vest ratably January 21, 2016 to December 1, 2016 and expire December 1, 2019.  

Option issuances and vesting during the nine month period ending March 31, 2017

On December 1, 2016, 480,000 options were granted to the Company’s Chief Executive Officer as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2017 and expire December 1, 2020.  Year to date expense related to these options is $583 as of March 31, 2017. 

As of March 31, 2017, there was $ 1,021 of unrecognized stock-based compensation expense related to stock options that will be recognized over the vest period of the underlying option.

We estimated the fair value of the stock options granted in the current fiscal year above at the grant date based on the following weighted average assumptions:
 
Risk free interest rate
 
 
1.450
Expected life
 
 
3.0
 years 
Expected volatility
 
 
126.36
Dividend yield
 
 
0.00
 
Year to date expense related to these options is $15,660 as of March 31, 2017.


AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
March 31, 2017

NOTE 6 - STOCK OPTIONS AND WARRANTS, Continued

A summary of the status of our outstanding stock options as of March 31, 2017 and June 30, 2016, and changes during the periods then ended is presented below:
  
 
 
March 31, 2017
   
June 30, 2016
 
 
       
Weight Average
 
Intrinsic
         
Weight Average
 
Intrinsic
 
 
 
Shares
   
Exercise Price
 
Value
   
Shares
   
Exercise Price
 
Value
 
Outstanding beginning of period
   
3,800,000
   
$
0.13
         
2,270,000
   
$
0.14
     
Granted
   
480,000
   
$
0.10
         
1,530,000
   
$
0.10
     
Expired/Cancelled
   
-
   
$
0.00
         
-
   
$
0.00
     
Exercised
   
-
   
$
0.00
         
-
   
$
0.00
     
Outstanding end of period
   
4,280,000
   
$
0.12
   
$
-
     
3,800,000
   
$
0.13
   
$
-
 
Exercisable
   
3,960,000
   
$
0.12
   
$
-
     
3,070,000
   
$
0.13
   
$
-
 

 


The following table summarizes the range of outstanding and exercisable options as of March 31, 2017:

     
Outstanding
   
Exercisable
 
Range of
Exercise Prices
   
Number Outstanding
at
March 31, 2017
   
Weighted
Average
Remaining
Contractual Life
   
Weighted
Average
Exercise Price
   
Number
Exercisable at
March 31, 2017
   
Weighted
Average Remaining
Contractual Life
 
$
0.08
     
150,000
     
4.67
   
$
0.08
     
150,000
     
4.67
 
$
0.10
     
2,680,000
     
2.35
   
$
0.10
     
2,360,000
     
2.35
 
$
0.17
     
1,450,000
     
3.67
   
$
0.17
     
1,450,000
     
3.67
 
         
4,280,000
                     
3,960,000
         

General Warrant Information

In September 2013, the Company obtained an extension on the remaining $100,000 secured convertible promissory note that was issued in the private placement that closed in September 2010.  This note was paid off as of June 30, 2015.   In exchange for the extension, the note holder received 500,000 common stock warrants and $6,500 in accrued interest and fees.  The common stock warrants expire three years from the date of issuance, are exercisable at $0.13 per share, and vest on the next date the value of Amerityre common stock reaches $0.25 per share.  As of September 30, 2016 the warrants expired.

NOTE 7 – STOCK AWARDS AND ISSUANCES

On January 21, 2017, 60,000 shares were granted to the Company’s Chief Financial Officer as part of her employment renewal.  The shares are valued as of January 20, 2017 ($0.04) and vest ratably through December 2017.

As of January 31, 2017, 225,000 shares were granted to the Company’s Board of Director’s as Board compensation for the term ending November 2017.  Each non-executive Board member receives 50,000 shares, with the Audit Committee Chair receiving 75,000 shares.  The shares vest ratably January – December 2017, valued at a fixed rate of $0.0155, the closing stock price on January 31, 2017.


AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
March 31, 2017

On March 23, 2017, the Company’s Chief Executive Officer, finalized the negotiation of the replacement and extension of his employment contract.  While all material compensation terms were finalized February 23, 2017 other items within the agreement, filed via Form 8-k on March 27, 2017, were finalized as of March 23, 2017. The Agreement replaces the current employment agreement and extends his term of employment to December 31, 2018.  Inclusive in this new agreement is a stock award of 2.4 million shares of the Company’s common stock vesting ratably over twenty-three months (February 2017 – December 2018),  valued at a fixed rate of $0.0168, the closing stock price on February 22, 2017.

As all of the above awards may be issued once vested, the Company is accounting for the above in stock payable.  As of March 31, 2017 stock payable is $5,047.

On February 23, 2017 the Board of Director’s approved a partial payment of Mr. Sullivan’s 2016 bonus in stock.  This partial payment of $5,000 resulted in the issuance of 322,581 shares of stock.

NOTE 8 – INCOME TAXES

As of March 31, 2017 the Company has net income year to date.  As such, the Company is working with its tax professionals to utilize available net operating loss carryforwards.  Due to the difference between our taxed effected net income as of this period end and the net operating loss of approximately $17,300,000 as of June 30, 2016, the Company continues to apply a 100% valuation allowance on any remaining deferred tax asset.

NOTE 9 - SUBSEQUENT EVENTS

 In April 2017, the Board of Directors closed the Amerityre Corporation 2015 Omnibus Stock Option and Award Plan as all units under the plan had been expended.  Contemporaneous with this, the Board approved the Amerityre Corporation 2017 Omnibus Stock Option and Award Plan for a total of 3,000,000 shares of the Company’s common stock.


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance or financial condition.  Such statements are only predictions and the actual events or results may differ materially from the results discussed in or implied by the forward-looking statements. The historical results set forth in this discussion and analysis are not necessarily indicative of trends with respect to any actual or projected future financial performance.  This discussion and analysis should be read in conjunction with the financial statements and the related notes thereto included elsewhere in this report.
 
Overview

Amerityre engages in the research and development, manufacturing and sale of polyurethane tires.  We believe that we possess unique polyurethane formulations that allow us to manufacture products with superior performance characteristics in the areas of abrasion resistance, energy efficiency and load-bearing capabilities, when compared to conventional rubber tires.  We also believe that our manufacturing processes are more energy efficient than traditional rubber tire manufacturing processes, in part because our polyurethane compounds do not require the multiple processing steps and extreme heat and high pressure necessary to cure rubber. Using our polyurethane technologies, we believe we produce tires that last longer, are less susceptible to failure and are friendly to the environment.  
 
We are concentrating on three segments of the tire market: closed-cell polyurethane foam tires, polyurethane elastomer tires and agricultural tires. We continue to focus on applications and markets where our advantages in product technology give us an opportunity to provide unique products and obtain premium pricing. Our most recent activities in these areas are set forth below:
 
Closed-Cell Polyurethane Tires – The sale of polyurethane foam tires to original equipment manufacturers, tire distributors and tire dealers accounts for the majority of our revenue. During the recent quarter this market segment represented over 95% of our total sales. We have the ability to produce a broad range of products for the light duty tire market. Our efforts in product development and marketing focus on building customer relationships with original equipment manufacturers and tire distributors.  We continue to create unique product solutions for customers with specific tire size and performance requirements.
 
Polyurethane Elastomer Tires – During the fourth quarter of fiscal year 2016 we relaunched the forklift tire product line with select customers. Shipments of forklift tires restarted during the recent quarter. We continue to develop new elastomer tire products for specific customer applications, such as our new scissor lift tire. Sales in this market segment during the quarter were minimal, but we expect sales to increase in the coming quarters as our products are introduced to new customers and gain market acceptance. 

Agricultural Tires – Sales of agricultural tires continue to be negatively impacted by the downturn in farm commodity prices and farm income levels. Recent projections have indicated that crop prices and farm income will continue to remain at historically low levels during 2017, but there is optimism that   these levels may have reached bottom, with improvement expected in 2018. We continue to invest in marketing initiatives to educate the agricultural community about the benefits of our products, so we are well positioned to take advantage of the eventual rebound in farm income.  We continue to pursue additional distribution relationships, both domestically and internationally, to increase our market penetration for our agricultural tires. The strength of the US dollar continues to provide a headwind to our international business. We continue development of new products in our seeder and haybaler tire lines in response to specific customer requirements.

Due to the Company’s limited resources, tire projects which are contingent on additional significant investment for development, such as  automotive tires, have been put on hold and will be revisited at a later date when funding becomes available.

As described above, our product line covers diverse market segments which are unrelated in terms of customer base, product, distribution, market demands and competition. Our sales team is comprised of three independent manufacturer representatives whose experience is complementary to our product portfolio, plus our in-house sales department.  The Company’s emphasis on proper product pricing and new marketing campaigns continues to drive higher margin and more profitable sales, as shown by our record results in quarter three of FY2017.  We continue to manage our costs to improve gross margins in the face of these difficult economic conditions in our target markets. We expect that this operational discipline will be key to maintaining profit margins going forward as we are beginning to experience increases in raw material costs. 


During our Annual Meeting in November 2016, the Company’s Senior Management outlined its strategic plan for increasing the Company’s sales, profitability, and market presence. This presentation was an update of the plan we unveiled during our previous annual meeting in November 2015. The continued improvement in our quarterly and year to date results for FY2017 are evidence that this strategy has been successful. As part of the most recent presentation, it was communicated that all required investments associated with this effort would be paid primarily by internally generated cash flow rather than relying on external financing. We successfully upgraded and launched our new website during the recent quarter, utilizing funding from a previously secured term loan.  We have successfully moved forward with marketing and product development initiatives in FY2017 at a pace that can be supported by our current level of business and cash generation.   Consequently we are not anticipating the need to do any fundraising activities in the near future to support our current strategic plan.

Since the recent U.S. Presidential and Congressional elections, there have been reports of expected  proposed changes to the U.S. tax code, tariffs on imported goods, and other legislation that could impact our business. To date none of this has come to pass. An emphasis on “Buy American” programs by our government, as well as OEMs who use flat free tires on their American made products, could positively impact our business, since Amerityre is a leading domestic manufacturer of flat free polyurethane tires. However, these types of changes are usually slow to be implemented and predicting when any benefits may appear is impossible, Amerityre management has chosen to proceed with its strategic plan irrespective of any potential or pending changes to trade legislation. We believe that this plan will be successful regardless of the political landscape, although we acknowledge that some of the rumored legislation could provide a tailwind for our business if it was to be enacted.

Factors Affecting Results of Operations
 
Our operating expenses consisted primarily of the following:
 
·
Cost of sales, which consists primarily of raw materials, components and production of our products, including applied labor costs and benefits expenses, maintenance, facilities and other operating costs associated with the production of our products;

·
Selling, general and administrative expenses, which consist primarily of salaries, commissions and related benefits paid to our employees and related selling and administrative costs including professional fees;

·
Research and development expenses, which consist primarily of contractor and direct labor conducting research and development, equipment and materials used in new product development and product improvement using our technologies;

·
Consulting expenses, which consist primarily of amounts paid to third-parties for outside services;

·
Depreciation and amortization expenses which result from the depreciation of our property and equipment, including amortization of our intangible assets; and

·
Stock based compensation expense related to stock and stock option awards issued to employees and consultants for services performed for the Company.

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with United States generally accepted accounting principles.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses.  On an ongoing basis, we evaluate our estimates, including those related to uncollectible receivables, inventory valuation, deferred compensation and contingencies.  We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances.  These estimates allow us to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

We believe the following accounting policies are our critical accounting policies because they are important to the portrayal of our financial condition and results of operations and they require critical management judgments and estimates about matters that may be uncertain.  If actual results or events differ materially from those contemplated by us in making these estimates, our reported financial condition and results of operations for future periods could be materially affected.


Revenue Recognition

Revenue for products is recognized when the sales amount is determined, shipment of goods to the customer has occurred and collection is reasonably assured. Generally, we ship all of our products FOB origination.
 
Valuation of Intangible Assets and Goodwill

Patent and trademark costs have been capitalized at March 31, 2017, totaling $479,633 with accumulated amortization of $324,727 for a net book value of $154,906.  Patent and trademark costs capitalized at March 31, 2016, totaled $479,633 with accumulated amortization of $297,421 for a net book value of $182,212.

The patents which have been granted are being amortized over a period of 20 years. Patents which are pending or are being developed are not amortized. Amortization begins once the patents have been issued. As of March 31, 2017 and 2016, respectively, there were no pending patents.  Annually, pending or expired patents are inventoried and analyzed, which resulted in the recognition of a loss on abandonment, expiration or retirement of patents and trademarks of $-0- for each of the years ended March 31, 2017 and 2016, respectively.

Amortization expense for the years ended March 31, 2017 and 2016 was $20,473 and $20,498 respectively.  The Company evaluates the recoverability of intangibles and reviews the amortization period on a continual basis utilizing the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350, Intangibles – Goodwill and Other.  We consider the following indicators, among others, when determining whether or not our patents are impaired:
 
·
any changes in the market relating to the patents that would decrease the life of the asset;

·
any adverse change in the extent or manner in which the patents are being used;

·
any significant adverse change in legal factors relating to the use of the patents;

·
current period operating or cash flow loss combined with our history of operating or cash flow losses;

·
future cash flow values based on the expectation of commercialization through licensing; and

·
current expectations that, more likely than not, the patents will be sold or otherwise disposed of significantly before the end of its previously estimated useful life.
 
Inventory
 
Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable. The cost of finished goods includes the cost of raw material, direct and indirect labor, and other indirect manufacturing costs. The inventory consists of chemicals, finished goods produced in the Company’s plant and products purchased for resale.

Stock-Based Compensation
 
We account for stock-based compensation under the provisions of FASB ASC 718, Compensation – Stock Compensation.  Our financial statements as of and for the periods ended March 31, 2017 and 2016 reflect the impact of FASB ASC 718. Stock-based compensation expense recognized under FASB ASC 718 for the fiscal years ended March 31, 2017 and 2016 was $25,706 and $56,238, respectively, related to employee stock options and employee stock grants.


FASB ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations. Stock-based compensation expense recognized in our Statements of Operations for fiscal years ended March 31, 2017 and 2016 assume all awards will vest; therefore no reduction has been made for estimated forfeitures.
 
Results of Operations
 
Our management reviews and analyzes several key performance indicators in order to manage our business and assess the quality and potential variability of our sales and cash flows.  These key performance indicators include:
 
·
Sales consisting of product sales;

·
Sales, net of returns and trade discounts, which is an indicator of our overall business growth and the success of our sales and marketing efforts;

·
Gross profit, which is an indicator of both competitive pricing pressures and the cost of goods sold of our products and the mix of product and license fees, if any;

·
Growth in our customer base, which is an indicator of the success of our sales efforts; and

·
Distribution of sales across our products offered.
 
The following summary table presents a comparison of our results of operations for the three and nine months ended March 31, 2017 and 2016 with respect to certain key financial measures.  The comparisons illustrated in the table are discussed in greater detail below. 
 
 
 
For the Three Months Ended
March 31,
         
For the Nine Months Ended
March 31,
       
 
 
(in 000’s)
   
Change
   
(in 000’s)
   
Change
 
 
 
2017
   
2016
   
2017 vs. 2016
   
2017
   
2016
   
2017 vs. 2016
 
Net revenues
 
$
1,134
   
$
936
     
21.2
%
 
$
2,849
   
$
2,865
     
(0.6
%)
Cost of  revenues
   
(694
)
   
(618
)
   
12.3
%
   
(1,861
)
   
(2,082
)
   
(10.6
%)
Gross profit
   
440
     
318
     
38.4
%
   
988
     
783
     
26.2
%
Research  and development expenses
   
(54
)
   
(57
)
   
(5.3
%)
   
(163
)
   
(166
)
   
(1.8
%)
Sales and marketing expense
   
(65
)
   
(54
)
   
20.4
%
   
(191
)
   
(220
)
   
(13.2
%)
General and administrative expense
   
(171
)
   
(172
)
   
(0.5
%)
   
(511
)
   
(667
)
   
(23.4
%)
Other income (expense)
   
(2
)
   
-
     
100.0
%
   
(7
)
   
(2
)
   
250.0
%
Net income (loss)
   
148
     
35
     
322.9
%
   
116
     
(272
)
   
(142.6
%)
Preferred stock dividend
   
(25
)
   
(25
)
   
0.0
%
   
(75
)
   
(75
)
   
0.0
%
Net income (loss) attributable to common shareholders
 
$
123
   
$
10
     
1130
%
 
$
41
   
$
(347
)
   
(111.8
%)
 
Results for quarter three FY2017 represent record quarterly net income results for Amerityre. Increased closed cell foam tire sales were the main driver for the higher sales revenue for the quarter. As expected, the agricultural tire segment continued to be weak as farmers remained cautious with their equipment purchases in an environment of depressed farmer income. For the nine month period ending March 31, 2017, sales are basically flat year over year, but gross profit and net income show dramatic improvements over the period compared with the same period in FY2016. Like many businesses, we are cautiously optimistic that general economic conditions will continue to improve, which will help maintain revenues at the higher levels than we experienced during the recent quarter.


Three Months Ended March 31, 2017 Compared to March 31, 2016

Net Sales.  Net sales of $1,133,610 for the quarter ended March 31, 2017, represents a 21.2% increase over net sales of $936,612 for the same period in 2016. These results were better than our expectations as increased optimism for a better general economy improved demand from many of our customers. Our sales were driven primarily by closed cell foam tire sales, where we continue to have a positive response to our marketing and pricing plans. Our forecast for the remainder of fiscal 2017 anticipates continued depressed agricultural tire sales, due to the continuation of the conditions causing depressed farm income.  We expect our polyurethane foam products to constitute the majority of our sales during the remainder of fiscal year 2017.
 
Cost of Revenues.  Cost of revenues for the quarter ended March 31, 2017 was $693,500 or 61.2% of sales compared to $618,366 or 66.0% of sales for the same period in 2016. Cost of revenues were higher due to increased sales levels, however as a percentage of sales cost of revenues was approximately 5% lower than the same period in 2016. This improvement was due to lower raw material costs compared with the previous year as well as better control of other costs due to better production efficiencies.  The Company continues to maintain sufficient production capacity to meet anticipated customer demand without incurring a proportionate increase in overall production costs. 

Gross Profit.  Gross profit for the quarter ended March 31, 2017 was $440,110 compared to $318,246 for the same period in 2016. Gross profit increased by $121,864, or 38.3% over the same period in 2016, due to increased sales as noted above.  The March 31, 2017 gross profit reflects a 38.8% gross margin on product sales compared to a gross margin on product sales of 34.0% in the quarter ending March 31, 2016.
 
Research & Development Expenses (R&D).  Research and development expenses for the quarter ended March 31, 2017 were $54,130 compared to $56,839 for the same period in 2016. We continue to focus our R&D efforts on product formulation optimization and new product development.  The Company plans to maintain this level of expenditure as R&D is a key component of the company’s business improvement initiatives.
 
Sales & Marketing Expenses. Sales and marketing expenses for the quarter ended March 31, 2017 were $65,000 as compared to $53,639 for the same period in 2016. Sales and marketing expenses increased between periods primarily due to higher sales commissions offset by lower salary and travel costs.

General & Administrative Expenses.  General and administrative expenses for the quarter ended March 31, 2017 were $170,813 compared to $172,270 for the same period in 2016.  These results remained level with the previous year’s results due to management’s continued focus on cost control as part of the Company’s strategic operating plan.

Other Expense.  Other expense for the quarter ended March 31, 2017 was ($1,703) compared to ($842) for the same period in 2016. Other expense consists solely of interest expense and increased in the period due to our new bank debt facilities.
 
Net Income.  Net income for the quarter ended March 31, 2017 of $148,464 represents a 322.9% improvement compared to the net income for the quarter ended March 31, 2016 of $34,656.  Continued successful implementation of the Company’s strategic plan resulted in cost savings and improved revenues resulting in record quarterly results.

Nine months Ended March 31, 2017 Compared to March 31, 2016

Net Sales.  Net sales of $2,849,370 for the nine months ended March 31, 2017, represents a 0.6% decrease over net sales of $2,865,433 for the same period in 2016. These results were in line with our expectations as we anticipated that agricultural tire markets would remain weak. We continue to have a positive response to our marketing efforts for our polyurethane foam tires. Our forecast for remainder of fiscal 2017 anticipates continued depressed agricultural tire sales, due to the continuation of business conditions causing depressed farm income.  We are optimistic that the increase in closed cell polyurethane foam product sales we saw in the recent quarter will continue for the 4th quarter of FY2017.
 
Cost of Revenues.  Cost of revenues for the nine months ended March 31, 2017 was $ 1,861,288 or 65.3% of sales compared to $2,081,813 or 72.7% of sales for the same period in 2016. Cost of revenues were lower due to better manufacturing efficiencies, use of fully depreciated assets causing manufacturing depreciation expense to be lower, lower manufacturing repairs and maintenance, and lower manufacturing and shipping supplies, offset by increases in raw materials expenditures related to increased sales and higher direct labor cost when compared to the prior period.  The Company continues to maintain sufficient production capacity to meet anticipated customer demand without incurring a proportionate increase in overall production costs. 


Gross Profit.  Gross profit for the nine months ended March 31, 2017 was $988,082 compared to $783,620 for the same period in 2016. Gross profit increased by $204,462 or 26.1% over the same period in 2016 due to the factors discussed previously.  The March 31, 2017 gross profit reflects a 34.7% gross margin on product sales compared to a gross margin on product sales of 27.3% in the same period of 2016.
 
Research & Development Expenses (R&D).  Research and development expenses for the nine months ended March 31, 2017 were $163,174 compared to $166,406 for the same period in 2016. While research and development expenses are flat between the periods we continue to focus on product formulation research and new product development.  
 
Sales & Marketing Expenses. Sales and marketing expenses for the nine months ended March 31, 2017 were $191,191 compared to $219,898 for the same period in 2016. Sales and marketing expenses decreased $28,707 between periods primarily due to the impact of the company’s new commission program, lower salary costs, and lower travel costs, offset by increased trade show expenses related to our attendance at four trade shows during this nine month period.

General & Administrative Expenses.  General and administrative expenses for the nine months ended March 31, 2017 were $510,596 compared to $666,910 for the same period in 2016. This decrease between periods of $156,314 is driven by lower costs related to wages, stock based compensation, warranty expense and professional fees.

Other Expense.  Other expense for the nine months ended March 31, 2017 was ($6,667) compared to ($2,267) for the same period in 2016. Other expense consists solely of interest expense and increased in the period due to our new bank debt facilities.
 
Net Income (Loss).  Net income for the nine months ended March 31, 2017 of $116,454 represents a 142.6% improvement from the net loss for the nine months ended March 31, 2016 of ($271,861).  

Liquidity and Capital Resources
 
Our principal source of liquidity consists of cash and payments received from our customers.  We do not have any significant revolving credit arrangements.  Historically, our expenses have exceeded our sales, resulting in operating losses.  From time to time, we have obtained additional liquidity to fund our operations through the sale of shares of our common stock and the placement of short-term debt instruments.  At the end of fiscal years 2016 and early 2017, we were able to obtain term bank debt financing to finance critical manufacturing and facility equipment and operating enhancements which will be placed in service in fiscal year 2017. Improvements in our operating results and general cash position have prompted us to refrain from outside financing.  Additionally, management has notified our preferred shareholder that we will be suspending future payments of their preferred cash dividend payments, so the Company can increase its working capital levels.

We have historically not succeeded in establishing favorable revolving short term financing such as lines of credit. In the quarter ended March 31, 2015, we entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed. As of  March 31, 2017, we have not needed to activate this financing option due to increased focus on executing established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.
 
Cash Flows
 
The following table sets forth our cash flows for the quarters ended March 31, 2017 and 2016.
 
 
Nine months ended Mar. 31,
 
 
(in 000’s)
 
 
2017
 
2016
 
Net cash provided (used) by operating activities
 
$
273
   
$
(272
)
Net cash used by investing activities
   
(15
)
   
-
 
Net cash used by financing activities
   
(15
)
   
(80
)
Net increase (decrease) in cash during the period
 
$
243
   
$
(352
)
 

 
Net Cash Used by Operating Activities. Our primary sources of operating cash for the nine months ended March 31, 2017 came from collections from customers. Our primary use of operating cash was an increase in prepaid and other current assets, specifically related to renewal of insurance policies, and a decrease of accounts payable and accrued expenses.  Net cash provided by operating activities was $273,298 for the quarter ended March 31, 2017 compared to net cash used by operating activities of $272,473 for the same period in 2016. 

Non-cash items include depreciation and amortization and stock based compensation. Our net income was $116,454 for the nine months ended March 31, 2017 compared to a net loss of ($271,861) for the same period in 2016. The net income for fiscal 2017 included non-cash expenses for depreciation and amortization of $77,171 and stock-based compensation (both stock issued and options) of $20,706. As of March 31, 2016, depreciation and amortization was $116,338 and stock-based compensation (both stock issued and options) totaled $56,238.
  
Net Cash Used by Investing Activities.  Net cash used by investing activities was $15,187 for the nine months ended March 31, 2017 and $0 for the same period in 2016. For the nine months ended March 31, 2017 we purchased critical facility equipment of which $15,187 was paid in cash the remainder financed through bank financing.  

Net Cash Used by Financing Activities.  Net cash used by financing activities was $14,606 for the nine months ended March 31, 2017 and $79,925 for the same period in 2016. The primary use of cash for the quarter ended March 31, 2017 was payment toward the capital lease of $4,566 and payment of notes payable of $10,040.
 
Contractual Obligations and Commitments
 
The following table summarizes our contractual cash obligations and other commercial commitments at March 31, 2017.
 
 
Payments due by period
 
 
Total
   
Less than
1 year
   
1 to 3 years
   
3 to 5 years
   
After
5 years
 
 
   
Facility lease (1)
 
$
448,200
   
$
137,700
   
$
310,500
   
$
-
   
$
-
 
Capital lease (2)
   
10,077
     
7,285
     
2,792
     
-
     
-
 
Bank debt (3)
   
83,119
     
17,141
     
59,726
     
6,252
     
-
 
Total contractual cash obligations
 
$
541,396
   
$
162,126
   
$
373,018
   
$
6,252
   
$
-
 

(1)
In May 2015, we negotiated a five (5) year extension of the lease on our executive office and manufacturing facility located at 1501 Industrial Road, Boulder City, Nevada.  The property consists of a 49,200 square foot building.  We currently occupy all 49,200, inclusive of approximately 5,500 square feet of office space, situated on approximately 4.15 acres.  All other terms and conditions of the building lease remain in effect.
(2)
In July 2015, we entered into a capital lease for research and development equipment for $19,337.
(3)
In June and July 2016, in two separate bank promissory notes, we financed critical manufacturing and facility equipment and operating enhancements which will be placed in service throughout fiscal year 2017.
 
Cash Position, Outstanding Indebtedness and Future Capital Requirements
 
At May 9, 2017, our total cash balance was $457,018, none of which is restricted; accounts receivables was $266,143; and inventory, net of reserves for slow moving or obsolete inventory, and other current assets was $694,154. Our total indebtedness was $499,409 and includes $344,245 in accounts payable and accrued expenses, $17,822 in current portion of long-term debt, $9,525 in capital lease liability and $127,629 in long-term debt.
 
We have been working during the past year to improve our liquidity and access to capital resources. As we discussed in our November 2016 Shareholder meeting, we require more capital resources to execute our strategic business plan. However, we have decided to finance these initiates out of internal cash flow rather than pursue financing with banks or other financial institutions. While this may delay the implementation of some initiatives, we believe that raising external capital at this time is not the prudent cost of action at this time, and the key initiatives can be adequately financed from operating cash flow.


The Company currently does not have an existing revolving credit facility. In June and July 2016, in two separate bank promissory notes, we financed critical manufacturing and facility equipment and operating enhancements which will be placed in service in fiscal year 2017.  Over the past year, we have worked with our vendors to obtain extended credit terms and increase credit lines where needed. Additionally, we continue to focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted. We have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices for faster cash flow if required.
 
We are intent on focusing on the sale and distribution of profitable product lines. We are limiting our capital expenditures to that required to maintain current manufacturing capability or support business initiatives identified in our strategic sales plan.  We continue to work to reduce our overall costs wherever possible.

Management continues to execute its strategic plan focusing on “Profitability as a Mindset”.  Our emphasis on proper product pricing and new marketing campaigns has driven more profitable sales. This analysis, in some cases, has resulted in lost revenues as unprofitable sales have been discontinued. The Company continues to achieve improvement in results as we improve our efficiency which enables us to reduce our breakeven level of sales. We believe our program to establish “Profitability as a Mindset” is a success and we are committed to continuing these efforts to achieve higher levels of profitability. 

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations.  In connection with the preparation of our financial statements for the period ended March 31, 2017, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period. 

Off-Balance Sheet Arrangements
 
We do not currently have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts.


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to changes in prevailing market interest rates affecting the return on our investments but do not consider this interest rate market risk exposure to be material to our financial condition or results of operations.  We invest primarily in United States Treasury instruments with short-term (less than one year) maturities.  The carrying amount of these investments approximates fair value due to the short-term maturities.  Under our current policies, we do not use derivative financial instruments, derivative commodity instruments or other financial instruments to manage our exposure to changes in interest rates or commodity prices.
 
ITEM 4. CONTROLS AND PROCEDURES

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

As required by SEC Rule 13a-15(b), an evaluation was performed under the supervision and with the participation of our management, including our Chief Executive and Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective at the reasonable assurance level. There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.


PART II - OTHER INFORMATION
 
ITEM 1.  LEGAL PROCEEDINGS

None.
 
ITEM 1A. RISK FACTORS

For information regarding risk factors, see “Part I. Item 1A. Risk Factors,” in our Annual Report on Form 10-K for the year ended June 30, 2016.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.
 
ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

None.
 
ITEM 4.  MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.  OTHER INFORMATION

None.
 
ITEM 6.  EXHIBITS
 
10.2
   
31.1
 
 
31.2
 
 
32.1
 
 
32.2
 
 
101 INS
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
 
101 SCH
XBRL Taxonomy Extension Schema Document
 
 
101 CAL
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
101 DEF
XBRL Taxonomy Extension Definition Linkbase Document
 
 
101 LAB
XBRL Taxonomy Extension Label Linkbase Document
 
 
101 PRE
XBRL Taxonomy Extension Presentation Linkbase Document
 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated:  May 10, 2017
 
AMERITYRE CORPORATION
 
 
 
By:
 
 
 
/s/ Michael F. Sullivan
 
/s/ Lynda R. Keeton-Cardno
 
Michael F. Sullivan
Chief Executive Officer
(Principal Executive Officer)
 
Lynda R. Keeton-Cardno
Chief Financial Officer
(Principal Financial and Accounting Officer)
 
 

 
 
 
 
21
Amerityre Corp --06-30 0000945828 Yes No Smaller Reporting Company No 2017 Q3 0000945828 2017-03-31 0000945828 2016-06-30 0000945828 2017-01-01 2017-03-31 0000945828 2016-01-01 2016-03-31 0000945828 2016-07-01 2017-03-31 0000945828 2015-07-01 2016-03-31 0000945828 2015-06-30 0000945828 2016-03-31 0000945828 2017-05-10 0000945828 us-gaap:NotesPayableOtherPayablesMember 2016-07-01 2017-03-31 0000945828 us-gaap:NotesPayableOtherPayablesMember 2017-03-31 0000945828 us-gaap:NotesPayableOtherPayablesMember 2016-06-30 0000945828 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-01 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2017-03-31 0000945828 2015-07-31 0000945828 amty:OptionsGrantedDecember1_2015Member us-gaap:ChiefExecutiveOfficerMember 2015-12-01 2015-12-01 0000945828 amty:OptionsGrantedDecember1_2015Member us-gaap:ChiefExecutiveOfficerMember 2015-12-01 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMemberMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:AuditCommitteeChairMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMembersAndAuditoCommitteChairMember 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMembersAndAuditoCommitteChairMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:MinimumMember us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:MaximumMember us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 us-gaap:ChiefExecutiveOfficerMember 2016-12-01 2016-12-01 0000945828 us-gaap:ChiefExecutiveOfficerMember 2016-12-01 0000945828 us-gaap:ChiefExecutiveOfficerMember 2016-07-01 2017-03-31 0000945828 us-gaap:ConvertibleDebtMember 2013-09-30 0000945828 us-gaap:ConvertibleDebtMember 2013-09-01 2013-09-30 0000945828 2015-07-01 2016-06-30 0000945828 amty:OptionsAt0.08Member 2017-03-31 0000945828 amty:OptionsAt0.08Member 2016-07-01 2017-03-31 0000945828 amty:OptionsAt0.10Member 2017-03-31 0000945828 amty:OptionsAt0.10Member 2016-07-01 2017-03-31 0000945828 amty:OptionsAt017Member 2017-03-31 0000945828 amty:OptionsAt017Member 2016-07-01 2017-03-31 0000945828 2017-01-21 2017-01-21 0000945828 2017-01-21 0000945828 2017-01-31 2017-01-31 0000945828 amty:BoardMemberMember 2017-01-31 2017-01-31 0000945828 amty:BoardMembersAndAuditoCommitteChairMember 2017-01-31 2017-01-31 0000945828 2017-01-31 0000945828 us-gaap:ChiefExecutiveOfficerMember 2017-03-23 2017-03-23 0000945828 us-gaap:ChiefExecutiveOfficerMember 2017-02-22 0000945828 2017-02-23 2017-02-23 0000945828 us-gaap:SubsequentEventMember 2017-04-30 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure
EX-10.2 2 ex10-2.htm
Exhibit 10.2
 
AMERITYRE CORPORATION
2017 OMNIBUS STOCK OPTION AND AWARD PLAN

Adopted by the Board: April 25, 2017

1. PURPOSE.
 
1.1.           The purpose of the Plan is to provide a means by which selected employees, directors and consultants of the Amerityre Corporation (the “Company”) are encouraged to perform through the opportunity to benefit from increases in value of the common stock of the Company (“Common Stock”) by grants of options to purchase the Common Stock (“Options”), or by awards of restricted Common Stock (“Stock”).
 
1.2.           The Company, by means of the Plan, seeks to retain the services of persons who are now employees, directors, or consultants to the Company, to secure and retain the services of new employees, directors and consultants, and to provide incentives for such persons to exert maximum efforts towards the success of the Company.
 
1.3.           All Options granted under the Plan shall be separately designated as Incentive Stock Options or Non-Qualified Stock Options at the time of grant, and in such form as issued pursuant to section 6 below, and the number of shares of common stock will be listed in the name of the employee, director or consultant in the Company’s stock records for shares purchased on exercise of each type of Option by said individual. All Stock may be designated as partially or immediately vested per the provisions of each grant.
 
2. DEFINITIONS.
 
“Act” means the Securities Act of 1933, as amended.
 
“Award” means the grant of an Option or of Stock.
 
“Board” means the Board of Directors of the Company.
 
“Code” means the Internal Revenue Code of 1986, as amended, and any Internal Revenue Code adopted in the future to replace the Internal Revenue Code of 1986.
 
“Committee” means the Compensation Committee or any other committee appointed by the Board in accordance with subsection C of Section 3 to administer the Plan, or the Board acting in lieu of such committee if not established. The Committee shall be composed of non-employee directors only.

 “Common Stock” means shares of the Company’s common stock, par value $0.001 per share.
 
“Company” means Amerityre Corporation, a Nevada corporation.
 
“Consultant” means any person, including an advisor, engaged by the Company to render consulting or other personal services as an independent contractor and who is compensated for such services, provided that the term “Consultant” shall not include Directors.
 
“Continuous Status as an employee, director or consultant” means that the provision of services to the Company in the capacity of employee, director or consultant, is not interrupted or terminated. Continuous Status as an employee, director or consultant shall not be considered interrupted in the case of (i) any approved leave of absence, (ii) transfers between locations of the Company or any successor, in any capacity as employee, director or consultant, or (iii) any change in status as long as the person remains in the service of the Company or successor in any capacity as an employee, director, consultant (except as otherwise provided in the applicable Option Agreement). An approved leave of absence shall include sick leave, military leave, or any other authorized personal leave approved by the Company; provided, however, that any such authorized leave of absence shall be treated as Continuous Status as an employee, director, or consultant for the purposes of vesting only to the extent as may be provided in the Company’s leave policy. For purposes of Incentive Stock Options, no such leave may exceed ninety (90) days, unless reemployment upon expiration of such leave is guaranteed by statute or contract. Notwithstanding anything to the contrary in this definitional paragraph, a Consultant’s status shall not be considered continuous unless the Consultant is and continues to be ready, willing and able to engage in substantial services to the Company. The Board, in its sole discretion, shall in all cases determine whether Continuous Status as an employee, director or Consultant shall be considered interrupted or terminated.
 
“Covered Employee” means any person who, on the last day of the taxable year, is the chief executive officer (or is acting in such capacity) or is among the four most highly compensated officers (other than the chief executive officer) of the Company for whom total compensation is required to be reported to stockholders under the Exchange Act, as determined for purposes of Section 162(m) of the Code.
1


 
“Director” means a member of the Board.
 
“Employee” means any person, including officers and executive directors, employed by the Company as determined under the rules contained in Code Section 3401. Neither service as a director nor payment of a director’s fee by the Company shall be sufficient by itself to constitute “employment” by the Company.
 
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
 
“Executive Director” means an individual who is an officer of the Company and also serves as a member of the Board of Directors.

 “Fair Market Value” means, as of any date, the value of the Common Stock of the Company determined as follows:
  
(a)           If the Common Stock is readily tradable on an established securities market, the fair market value of the Common Stock on the date of grant means the value determined based upon the last sale before or the first sale after the grant, the closing price on the trading day before or the trading day of the grant of the Award, or any other reasonable basis using actual transactions in the Common Stock as reported by such market and consistently applied.
 
(b)           If the Common Stock is not readily tradable on an established securities market, the fair market value of the Common Stock on the date of grant means the value determined by a valuation of the Common Stock determined by an independent appraisal that meets the requirements of Section 401(a)(28)(C) of the Code and the regulations thereunder as of a date that is no more than 12 months before the relevant Option grant date.
 
“Incentive Stock Option” means an Option intended to qualify as an incentive stock option (as set forth in the Option Agreement) and that qualifies as an Incentive Stock Option within the meaning of Section 422 of the Code and the regulations promulgated thereunder.
 
“Non-Qualified Stock Option” means an Option not intended to qualify as an Incentive Stock Option (as set forth in the Option Agreement) or that does not qualify as an Incentive Stock Option.
 
“Officer” means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder.
 
“Option” means an option for the purchase of the Company’s common stock granted pursuant to the Plan.
 
“Option Agreement” means a written agreement between the Company and a recipient evidencing the terms and conditions of an individual Option grant. The Option Agreement shall be in the form approved by the Board from time to time. Each Option Agreement shall be subject to the terms and conditions of the Plan.
 
“Outside Director” means a Director who (i) is not a current employee of the Company or an “affiliated corporation” (within the meaning of Treasury regulations promulgated under Section 162(m) of the Code), (ii) is not a former employee of the Company receiving compensation for prior services (other than benefits under a tax qualified pension plan) during the taxable year, (iii) has not been an officer of the Company at any time, (iv) is not currently receiving direct or indirect remuneration (including any payment in exchange for goods or services) from the Company in any capacity other than as a Director, (v) is otherwise considered an “outside director” for purposes of Section 162(m) of the Code, a “non-employee director” for purposes of Rule 16b-3 under the Exchange Act.
 
“Plan” means this Amerityre Corporation 2015 Stock Option and Incentive Plan.
 
“Purchase Price” is defined in Subsection C of section VI below.
 
2

 
“Recipient” means an Employee, Director or Consultant, or their transferees, who holds an outstanding Option.
 
 “Rule 16b-3” means Rule 16b-3 of the Exchange Act or any successor to Rule 16b-3, as in effect when discretion is being exercised with respect to the Plan.

“Stock” means an awarded grant of the Company’s restricted Common Stock.
 
3. ADMINISTRATION.
 
3.1.        The Plan shall be administered by the Board unless and until the Board delegates administration to the Committee, as provided in subsection (c) of this Section 3.2 below.
 
3.2.        The Board shall have the power, subject to, and within the limitations of, the express provisions of the Plan:
 
(a)           To determine, in its sole discretion, from time to time which of the persons eligible under the Plan shall be granted an Award; when and how each Award shall be granted; whether an Option granted will be an Incentive Stock Option, a Non-Qualified Stock Option, or an award of Stock, or a combination of the foregoing; the provisions of each Award granted (which need not be identical), including the time or times when a person shall be permitted to receive stock pursuant to an Award; the number of shares with respect to which an Award shall be granted to each such person; and all other terms, conditions and restrictions applicable to each such Award or shares acquired upon exercise of an Option not inconsistent with the terms of the Plan.
 
(b)           To approve one or more forms of Option Agreement.
 
(c)           To construe and interpret, in its sole discretion, the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Option Agreement, in a manner and to the extent it shall deem necessary or expedient to make the Plan fully effective.
 
(d)           To amend, modify or otherwise change in any manner the Plan or an Award as provided in Section 13 and to suspend or terminate the Plan as provided in Section 13.
 
(e)           Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company that are not in conflict with the provisions of the Plan.
 
All decisions, determinations and interpretations of the Board shall be final, binding and conclusive on any Recipient and any other person with an interest in the Plan or in an Award and on any Affiliate.
 
3.3.          The Board may delegate administration of the Plan to the Committee which will be composed of not fewer than two (2) of its members. Furthermore, notwithstanding anything in this section 3 to the contrary, the Board may delegate to the Committee the exclusive right and authority to award Options or Stock to an eligible person who is a Covered Employee or who is expected to be a Covered Employee at the time of recognition of income resulting from such Award with respect to either of whom the Company wishes to avoid the application of Section 162(m) of the Code.
 
The Committee shall have, during such delegation and in connection with the administration of the Plan, the powers theretofore possessed by the Board (and references in this Plan to the Board shall thereafter be to the Committee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. Administration of the Plan shall encompass, among other things, determining potential Award recipients, establishing the terms of each Award, ensuring all proposed grants are consistent with the terms of the Plan, granting Awards and ensuring the Corporate Secretary keeps accurate records of options granted and exercised and stock awarded.
 
The Board may withdraw administration of the Plan from the Committee at any time. The Board may abolish the Committee at any time and, upon abolition administration of the Plan shall revert automatically, without any further action on the Board's part, to the Board.

3.4.          No member of the Board or of any committee constituted under this Section 3 or any Officer acting pursuant to this Section shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or any Award.
 
3


4. SHARES SUBJECT TO THE PLAN.
 
4.1.          Subject to the provisions of Section 11 relating to adjustments upon changes in stock, the amount of stock that may be issued pursuant to the grant and exercise of Awards shall not exceed in the aggregate three million (3,000,000) shares of the Company’s Common Stock. If any Award shall for any reason expire or otherwise terminate, in whole or in part, without having been exercised in full, the shares not acquired underlying such Award shall revert to and again become available for issuance under the Plan. 

4.2.        The Common Stock subject to the Plan may be unissued shares or reacquired shares, bought on the market or otherwise.
 
5. ELIGIBILITY.
 
5.1.        Incentive Stock Options may be granted only to Employees. Non-Qualified Stock Options may be granted to Employees, Directors or Consultants. Stock may be granted to any of the above.
 
5.2.        No person shall be eligible for the grant of an Incentive Stock Option if, at the time of grant, such person owns (or is deemed to own pursuant to Section 424(d) of the Code) stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company (a “Ten Percent Stockholder”), unless the exercise price of such Option is at least one hundred ten percent (110%) of the Fair Market Value of such stock at the date of grant and the Option is not exercisable after the expiration of five (5) years from the date of grant.
 
5.3.        To the extent that the aggregate Fair Market Value (determined at the time of grant) of stock with respect to which Incentive Stock Options are exercisable for the first time by any Recipient during any calendar year under all plans of the Company exceeds one hundred thousand dollars ($100,000), the Options or portions thereof which exceed such limit (according to the order in which they were granted) shall be treated as Non-Qualified Stock Options.
 
6. TERMS OF OPTIONS.
 
Each Option shall be evidenced by an Option Agreement in such form and shall contain such terms and conditions as the Board shall deem appropriate. No Option or purported Option shall be a valid and binding obligation of the Company unless evidenced by a fully executed Option Agreement. The provisions of separate Options need not be identical, but each Option shall include (through incorporation of provisions hereof or as specifically set forth in the Option Agreement or otherwise) the substance of each of the following provisions:
 
6.1.        Term. No Incentive Stock Option shall be exercisable after the expiration of ten (10) years from the date it was granted. However, in the case of an Incentive Stock Option granted to a Recipient who, at the time the Option is granted, is a Ten Percent Stockholder (as described in subsection B of Section V), the term of the Option shall be five (5) years from the date of grant thereof or such shorter term as may be provided in the Option Agreement.
 
6.2.        Price. The exercise price of each Option shall be not less than one hundred percent (100%) of the Fair Market Value of the stock subject to the Option on the date the Option is granted. Notwithstanding the foregoing, an Option (whether an Incentive Stock Option or a Non-Qualified Stock Option) may be granted with an exercise price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 424(a) of the Code.
 
6.3.        Consideration. The purchase price of stock acquired pursuant to an Option (the “Purchase Price”) shall be paid, to the extent permitted by applicable statutes and regulations, either (i) in cash or check at the time the Option is exercised, or (ii) as set forth in the Option Agreement (or in the case of a Non-Qualified Stock Option, as subsequently determined in the discretion of the Board or the Committee) in shares of Common Stock that have been owned by the optionee for more than six months or by the surrender of Options to acquire Common Stock from the Company that have been held for more than six months, which Common Stock or Options shall be valued at their Fair Market Value as determined by the Board or a duly authorized committee as of the business day immediately preceding the date of such exercise.
 
4

 
6.4.        Transferability. An Incentive Stock Option shall not be transferable except by will or by the laws of descent and distribution, and shall be exercisable during the lifetime of the Recipient only by such Recipient or by his attorney-in-fact or conservator, unless such exercise by the attorney-in-fact or the conservator of the Recipient would disqualify the Incentive Stock Option as such. Unless the Board otherwise specifies, a Non-Qualified Stock Option shall not be transferable except by will or by the laws of descent and distribution and shall be exercisable during the lifetime of the Recipient only by such person or by his attorney-in-fact or conservator. Notwithstanding the foregoing, the Recipient may, by delivering written notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the Recipient, shall thereafter be entitled to exercise the Option.

6.5.        Vesting. The total number of shares of stock subject to an Option may be allotted in installments (which may, but need not, be equal). The Option Agreement may provide that from time to time during each of such installment periods, the Option may become exercisable (“vest”) with respect to some or all of the shares allotted to that period, and may be exercised with respect to some or all of the shares allotted to such period and/or any prior period as to which the Option became vested but was not fully exercised. The Option may be subject to such other terms and conditions on the time or times when it may be exercised (which may be based on performance or other criteria) as the Board may deem appropriate. Any vesting schedule can be accelerated in the discretion of the Board, unless otherwise specified in the Option Agreement.
 
6.6.        Termination of Employment or Relationship as a Director or Consultant. In the event a Recipient’s Continuous Status as an Employee, Director or Consultant terminates (other than upon the Recipient’s death or disability), the Recipient may exercise his or her Option (to the extent that the Recipient was entitled to exercise it at the date of termination) but only within such period of time ending on the earlier of (i) the date three (3) months after the termination of the Recipient’s Continuous Status as an Employee, Director or Consultant (or, such longer or shorter period specified in the Option Agreement), or (ii) the expiration of the term of the Option as set forth in the Option Agreement. If, at the date of termination, the Recipient is not entitled to exercise his or her entire Option, the shares covered by the unexercisable portion of the Option shall revert to and again become available for issuance under the Plan. If, after termination, the Recipient does not exercise his or her Option within the time specified in the Option Agreement or in this Plan, the Option shall terminate, and the shares covered by such Option shall revert to and again become available for issuance under the Plan. The above terms shall apply only if the specific Option grant is silent on the above issues; however, a specific Option grant may provide for different terms in the event a Recipient’s Continuous Status as an Employee, Director or Consultant terminates (other than upon the Recipient’s death or disability).
 
6.7.        Disability of Recipient. In the event a Recipient’s Continuous Status as an Employee, Director or Consultant terminates as a result of the Recipient’s disability, as defined in Section 22(e)(3) of the Code, the Recipient may exercise his or her Option (to the extent that the Recipient was entitled to exercise it at the date of termination), but only within such period of time ending on the earlier of (i) the date twelve (12) months following such termination (or, such longer or shorter period specified in the Option Agreement), or (ii) the expiration of the term of the Option as set forth in the Option Agreement. If, at the date of termination of Continuous Status, the Recipient is not entitled to exercise his or her entire Option, the shares covered by the unexercisable portion of the Option shall revert to and again become available for issuance under the Plan. If, after termination, the Recipient does not exercise his or her Option within the time specified herein, the Option shall terminate, and the shares covered by such Option shall revert to and again become available for issuance under the Plan. The above terms shall apply only if the specific Option grant is silent on the above issues; however, a specific Option grant may provide for different terms in the event a Recipient’s Continuous Status as an Employee, Director or Consultant terminates as a result of the Recipient’s disability.
 
6.8.        Death of Recipient. In the event of the death of a Recipient during, or within a period specified in the Option after the termination of, the Recipient’s Continuous Status as an Employee, Director or Consultant, the Option may be exercised (to the extent the Recipient was entitled to exercise the Option at the date of death) by the Recipient’s estate, by a person who acquired the right to exercise the Option by bequest or inheritance or by a person designated to exercise the option upon the Recipient’s death but only within the period ending on the earlier of (i) the date twelve (12) months following the date of death (or, such longer or shorter period specified in the Option Agreement), or (ii) the expiration of the term of such Option as set forth in the Option Agreement. If, at the time of death, the Recipient was not entitled to exercise his or her entire Option, the shares covered by the unexercisable portion of the Option shall revert to and again become available for issuance under the Plan. If, after death, the Option is not exercised within the time specified herein, the Option shall terminate, and the shares covered by such Option shall revert to and again become available for issuance under the Plan. The above terms shall apply only if the specific Option grant is silent on the above issues; however, a specific Option grant may provide for different terms in the event a Recipient’s Continuous Status as an Employee, Director or Consultant terminates as a result of the Recipient’s death.
 
6.9.        Responsibility for Option Exercise. A Recipient is responsible for taking any and all actions as may be required to exercise any Option in a timely manner, and for properly executing any documents as may be required for the exercise of an Option in accordance with such rules and procedures as may be established from time to time under the Plan. By signing or accepting an Option Agreement a Recipient (and any person to whom the Option under that Option Agreement is transferred) acknowledges that information regarding the procedures and requirements for the exercise of that Option is available upon such Recipient’s or person’s request to the Board. The Company shall have no duty or obligation to notify any Recipient of the expiration of any Option.
5



 7. TERMS OF STOCK AWARDS.
 
Each Award of Stock shall be evidenced by a Letter Agreement in such form and shall contain such terms and conditions as the Board shall deem appropriate. No Award of Stock shall be a valid and binding obligation of the Company unless evidenced by a fully executed Letter Agreement. The provisions of separate Awards of Stock need not be identical, but each Letter Agreement shall include (through incorporation of provisions hereof or as specifically set forth in the Letter Agreement or otherwise) the substance of each of the following provisions:
 
7.1.        Vesting. The total number of shares of Stock subject to an Award may be allotted in installments (which may, but need not, be equal). The Letter Agreement may provide that from time to time during each of such installment periods, the Stock may vest with respect to some or all of the shares allotted to that period. The Stock may be subject to such other terms and conditions on the time or times when it may vest in part or whole (which may be based on performance or other criteria) as the Board may deem appropriate. Any vesting schedule can be accelerated in the discretion of the Board, unless otherwise specified in the Letter Agreement.
 
7.2.        Termination of Employment or Relationship as a Director or Consultant. In the event a Recipient’s Continuous Status as an Employee, Director or Consultant terminates (other than upon the Recipient’s death or disability), the Recipient shall be entitled to retain his or her Stock to the extent that the Recipient was vested at the date of termination.  If, at the date of termination, the Recipient is not vested in the entire Award, the shares covered by the unvested portion of the Award shall revert to and again become available for issuance under the Plan. The above terms shall apply only if the specific grant of Stock is silent on the above issues; however, a specific grant of Stock may provide for different terms in the event a Recipient’s Continuous Status as an Employee, Director or Consultant terminates (other than upon the Recipient’s death or disability).
 
7.3.        Disability of Recipient. In the event a Recipient’s Continuous Status as an Employee, Director or Consultant terminates as a result of the Recipient’s disability, as defined in Section 22(e)(3) of the Code, the Recipient shall be entitled to retain his or her Stock to the extent that the Recipient was vested at the date of termination. If, at the date of termination of Continuous Status, the Recipient is not vested in his or her entire Award, the shares covered by the unvested portion of the Award shall revert to and again become available for issuance under the Plan. The above terms shall apply only if the specific grant of Stock is silent on the above issues; however, a specific grant of Stock may provide for different terms in the event a Recipient’s Continuous Status as an Employee, Director or Consultant terminates as a result of the Recipient’s disability.

7.4.        Death of Recipient. In the event of the death of a Recipient during, or within a period specified in the Award, the Recipient’s estate shall be entitled to retain the Stock to the extent the Recipient was vested in the Award at the date of death. If, after death, the Award is not fully vested, the unvested shares covered by such Award shall revert to and again become available for issuance under the Plan. The above terms shall apply only if the specific grant of Stock is silent on the above issues; however, a specific grant of Stock may provide for different terms in the event a Recipient’s Continuous Status as an Employee, Director or Consultant terminates as a result of the Recipient’s death.
 
8. REPRICING, CANCELLATION AND RE-GRANT
OF OPTIONS.
 
The Board or the Committee shall not effect at any time directly or indirectly the repricing of any outstanding Options, including without limitation a repricing by the cancellation of any outstanding Options under the Plan and the grant in substitution therefor of new Options under the Plan covering the same or different amount of shares of stock. Notwithstanding the foregoing, an Option (whether an Incentive Stock Option or a Non-Qualified Stock Option) may be granted with an exercise price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 424(a) of the Code.
 
6

 
9. COVENANTS OF THE COMPANY.
 
During the terms of the Awards, the Company shall keep available at all times the number of shares of Common Stock required to satisfy such Awards.

10. USE OF PROCEEDS FROM EXERCISE OF OPTIONS.
 
Proceeds from the exercise of Options shall constitute general funds of the Company.
 
11. MISCELLANEOUS.
 
11.1.        Neither an Employee, Director or Consultant nor any person to whom an Option may be transferred shall be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares subject to such Award unless and until such person has satisfied all requirements for exercise, which can include an early exercise of the Option pursuant to its terms and the Company has issued such shares.
 
11.2.        Nothing in the Plan or any instrument executed or Award granted pursuant thereto shall confer upon any Employee, Director, Consultant or other holder of Awards or Common Stock issued upon exercise of Options any right to continue in the employ of the Company (or to continue acting as a Director or Consultant) or shall affect the right of the Company to terminate the employment of any Employee with or without cause, the right of the Company’s Board of Directors and/or the Company’s stockholders to remove any Director pursuant to the terms of the Company’s Sections of Incorporation and By-Laws and the provisions of Nevada Law, or the right to terminate the relationship of any Consultant with the Company.
 
11.3.        If the Company is required to withhold any amounts by reason of federal, state or local tax laws, rules or regulations, in respect of the issuance of Awards or shares of stock pursuant to the Plan, the Company shall be entitled to deduct and withhold such amounts from any cash payments to be made to the Recipient. In any event, such person shall promptly make available to the Company, when requested by the Company, sufficient funds to meet the requirements of such withholding, and the Company may take and authorize such steps as it may deem advisable in order to have such funds made available to the Company from any funds or property due or to become due to such person. The exercise will not be effective until the Company has received such funds to cover the withholding.
 
11.4.        To the extent provided by the terms of an Option Agreement, and to the extent the Company agrees, through a vote of its Board, regarding a non-cash payment, the person to whom an Option is granted may satisfy any federal, state or local tax withholding obligation relating to the exercise or acquisition of stock under an Option by any of the following means or by a combination of such means: (i) tendering a cash payment; (ii) authorizing the Company to withhold shares from the shares of the stock otherwise issuable to the Recipient as a result of the exercise or acquisition of stock underlying the Option; or (iii) delivering to the Company unencumbered shares of the Company’s stock owned by the person acquiring the stock. The Fair Market Value of any shares of Common Stock withheld or tendered to satisfy any such tax withholding obligations shall not exceed the amount determined by the applicable minimum statutory withholding rules.
 
11.5.        The Company shall not be required to issue fractional shares pursuant to this Plan and, accordingly, a Recipient may be awarded or required to purchase only whole shares.

11.6.        The Plan and all determinations made and actions taken hereunder, to the extent not otherwise governed by the Code or laws of the United States, shall be governed by the laws of the State of Nevada and construed accordingly, without reference to the conflict of laws principles.
 
11.7.        The receipt, transfer and exercise of any Award is subject to taxation under Section 83 of the Code.
 
12. ADJUSTMENTS UPON CHANGES IN STOCK.
 
If any change is made in the stock subject to the Plan, or subject to any Award, without the receipt of consideration by the Company (through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt of consideration by the Company), the Plan will be appropriately adjusted in the class(es) and maximum number of shares subject to the Plan, and the outstanding Awards will be appropriately adjusted in the class(es) and number of shares and price per share of stock subject to such outstanding Awards. Such adjustments shall be made by the Board or the Committee, the determination of which shall be final, binding and conclusive. (The conversion of any convertible securities of the Company shall not be treated as a transaction not involving the receipt of consideration by the Company.)
 
7


13. AMENDMENT OF THE PLAN AND AWARDS.
 
13.1.       The Board at any time, and from time to time, may amend the Plan. However, except as provided in section 11 relating to adjustments upon changes in stock, no amendment shall be effective unless approved by the stockholders of the Company within twelve (12) months before or after the adoption of the amendment, where the amendment will:
 
(a)           Increase the number of shares reserved for Awards under the Plan;
 
(b)           Modify the requirements as to eligibility for participation in the Plan (to the extent such modification requires stockholder approval in order for the Plan to satisfy the requirements of Section 422 of the Code); or
 
(c)           Modify the Plan in any other way if such modification requires stockholder approval in order for the Plan to satisfy the requirements of Section 422 of the Code.
 
13.2.       The Board may in its sole discretion submit any other amendment to the Plan for stockholder approval, including, but not limited to, amendments to the Plan intended to satisfy the requirements of Section 162(m) of the Code and the regulations promulgated thereunder regarding the exclusion of performance-based compensation from the limit on corporate deductibility of compensation paid to certain executive officers.

13.3.        It is expressly contemplated that the Board may amend the Plan in any respect the Board deems necessary or advisable to provide eligible Employees, Directors or Consultants with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated thereunder relating to Incentive Stock Options and/or to bring the Plan and/or Incentive Stock Options granted under it into compliance therewith.
 
13.4.        Rights and obligations of the Recipient under any Award granted before amendment of the Plan shall not be materially impaired by any amendment of the Plan except with the written consent of the Recipient, unless such amendment is necessary to comply with any applicable law, regulation or rule as determined in the sole discretion of the Board.
 
13.5.        The Board at any time, and from time to time, may amend, modify, extend, cancel or renew any Award or waive any restrictions or conditions applicable to any Award or any shares acquired upon the exercise thereof and accelerate, continue, extend or defer the exercise time for any Award or the vesting of any shares acquired upon the exercise thereof, including with respect to the period following a Recipient’s termination of Continuous Status as an Employee, Director or Consultant; provided, however, that the rights and obligations under any Award shall not be materially impaired by any such amendment except with the written consent of the Recipient, unless such amendment is necessary to comply with any applicable law, regulation or rule as determined in the sole discretion of the Board.
 
The Board may accelerate the time at which an Option may first be exercised or the time during which an Option or any part thereof will vest notwithstanding the provisions in the Option Agreement stating the time at which it may first be exercised or the time during which it will vest.
 
13.6.        The Board may amend the Plan to take into account changes in law and tax and accounting rules, as well as other developments, and to grant Awards that qualify for beneficial treatment under such rules without stockholder approval.
 
14. TERMINATION OR SUSPENSION OF THE PLAN.
 
14.1.        The Board may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall terminate on August 10, 2025, which shall be within ten (10) years from the date the Plan is adopted by the Board or approved by the stockholders of the Company, whichever is later. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated.
 
8

 
14.2.        Rights and obligations under any Award granted while the Plan is in effect shall not be impaired by suspension or termination of the Plan, except with the written consent of the Recipient, unless such impairment is necessary to qualify the Award as an Incentive Stock Option or to comply with any applicable law, regulation or rule all as determined in the sole discretion of the Board.
 
15. EFFECTIVE DATE OF PLAN.
 
The Plan shall become effective as determined by the Board, but no Awards granted under the Plan shall be exercised unless and until the Plan has been approved by the stockholders of the Company, which approval shall be obtained within twelve (12) months before or after the date when the Plan is adopted by the Board.
 

16. COMPLIANCE WITH SECURITIES LAWS.
 
The grant of Awards and the issuance of shares of Common Stock upon the an award of Stock or upon exercise of Options shall be subject to compliance with all applicable requirements of federal and state law with respect to such securities. Options may not be exercised if the issuance of shares of Common Stock upon exercise would constitute a violation of any applicable federal or state securities laws or other laws or regulations or the requirements of any stock exchange or market system upon which the Common Stock may then be listed. In addition, no Option may be exercised unless (A) a registration statement under the Act shall at the time of exercise of the Option be in effect with respect to the Common Stock shares to be issued upon the exercise of that Option or (B) in the opinion of counsel to the Company, the Common Stock shares issuable upon exercise of the Option may be issued in accordance with the terms of an applicable exemption from the registration requirements of the Act. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Common Stock shares under the Plan shall relieve the Company of any liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained. As a condition of the exercise of any Option, the Company may require the Recipient to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company. The Company may, upon the advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock.
 
17. COMPLIANCE WITH SECTION 409A.
 
To the extent that the Board determines that any Award granted under the Plan is subject to Section 409A of the Code, the Option Agreement or other agreement evidencing the Award will incorporate the terms and conditions required by Section 409A of the Code. To the extent applicable, the Plan and Award agreements will be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the Plan's effective date. Notwithstanding any provision of the Plan to the contrary, in the event that following the Plan's effective date the Board determines that any Award may be subject to Section 409A of the Code and related Department of Treasury guidance (including such Department of Treasury guidance as may be issued after the Plan's effective date), the Board may adopt such amendment to the Plan and applicable Award agreements or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Board determines are necessary or appropriate to (a) exempt the Award from Section 409A of the Code and/or preserve the intended tax treatment of the benefits provided with respect to the Award, or (b) comply with the requirements of Section 409A of the Code and related Department of Treasury guidance.


9
EX-31.1 3 ex31-1.htm
EXHIBIT 31.1
 
CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael F. Sullivan, certify that:

1.           I have reviewed this quarterly report on Form 10-Q of Amerityre Corporation for the three and nine months ended March 31, 2017;

2.           Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.           The registrant’s other certifying office and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

(a)           designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)           designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)           presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation; and

(d)           disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.           The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)           all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)           any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2017
 
/s/ Michael F. Sullivan              
Michael F. Sullivan
Chief Executive Officer
(Principal Executive Officer)
 

EX-31.2 4 ex31-2.htm
EXHIBIT 31.2
 
CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lynda R. Keeton-Cardno, certify that:

1.           I have reviewed this quarterly report on Form 10-Q of Amerityre Corporation for the three and nine months ended March 31, 2017;

2.           Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.           The registrant’s other certifying office and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

(a)           designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)           designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)           presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation; and

(d)           disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.           The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)           all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)           any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2017
 
/s/ Lynda R. Keeton-Cardno                  
Lynda R. Keeton-Cardno
Chief Financial Officer
(Principal Financial Officer)
EX-32.1 5 ex32-1.htm
EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of Amerityre Corporation (the “Company”) on Form 10-Q for the three and nine months ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael F. Sullivan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley  Act of 2002, that, to the best of my knowledge and belief:

(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


/s/ Michael F. Sullivan                  
Michael F. Sullivan
Chief Executive Officer
(Principal Executive Officer)
May 10, 2017
EX-32.2 6 ex32-2.htm
EXHIBIT 32.2
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of Amerityre Corporation (the “Company”) on Form 10-Q for the three and nine months ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Lynda R. Keeton-Cardno, Chief  Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley  Act of 2002, that, to the best of my knowledge and belief:

(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


/s/ Lynda R. Keeton-Cardno                  
Lynda R. Keeton-Cardno
Chief Financial Officer
(Principal Financial Officer)
May 10, 2017

GRAPHIC 7 image0.jpg begin 644 image0.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** &BDYIU5;V\ALK9YYCA$ZU$IJ$>9@D22S1PQL M\CA4'4GI6!=>*X$8I:1F5O[YX6N7U'5KG5KC,C,D*M\D0Z?\"J>QM'NITAC' M)_\ ':\6>8SJ3Y*1W0PR4>:9NV-WJ>K7 7S!#"OWV1?TK4U;6++0-,DO;^;R MX85Y)ZGV'J:>!:Z+ISR2,L<,*;W<_J:\ \8^)[GQ=JI8;TL(6Q;P_P!3[FO6 MPU.2C[^YY>+Q,:>Q[MX=\1:=XGTQ;ZPD)0\.C<.A]#5/49]3TR8NDWFVS=-Z MYQ[&O#/#.O7GA354O+?<\+<7$/:1/_BJ^A;.ZLO$&D17,#"6VN$W*?\ />JK MTY2A[I.$Q4:FYG6OBN/(2\A,?^VG*UO6]S#=1!X9%=#W%<+J-@]I*LPG1GR5#U7AE./- ].[4E4--U&'4;1+B+IW7N M#Z5?KVZ=2,XW1QMP_.O/R>C?WV;XZK9RWM[-=W,N^XF?;=GSVERB_P!YHBM8M:NU=V<#/K65JLFJQ_\>44;K_$>_Y5A2HK#4[1+G+VKU([#POH M6EJ%LM)M(7V?\ 2FG4_P!U_EIHN?\ :K*6.?8J M.%B=MNA/1E/XU1O= T;4T*WNGVDX/]^($URYN5_O4)=7>?\ 17F8_P!U,M2C MCGV!X6)T6A>&],\.1SQ:7"T$4[[VCWD@'VS63XOLY9+NT>%&>238%B=\YY^6M*T5B*=I"IOV4M"MH&D?V79X?!G M?YG(_E6U@51L-02^\SRT8*A W'O5W-;4:5.$%%&4&I**KE$1HBJ.% ^E/I:*$@"BBBJ **** "BBB@ HHHH **** "BB $B@#_V0$! end EX-101.CAL 8 amty-20170331_cal.xml XBRL TAXONOMY EXTENSION - CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 amty-20170331_def.xml XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE EX-101.LAB 10 amty-20170331_lab.xml XBRL TAXONOMY EXTENSION - LABEL LINKBASE EX-101.PRE 11 amty-20170331_pre.xml XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE EX-101.SCH 12 amty-20170331.xsd XBRL TAXONOMY EXTENSION - SCHEMA 001 - Statement - Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Disclosure - NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - NOTE 3 - INVENTORY link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - NOTE 4 - DEBT link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - NOTE 5 - CAPITAL LEASE link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - NOTE 7 - STOCK AWARDS AND ISSUANCES link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - NOTE 8 - INCOME TAXES link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - NOTE 9 - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - NOTE 3 - INVENTORY (Tables) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - NOTE 4 - DEBT (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - NOTE 5 - CAPITAL LEASE (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - NOTE 3 - INVENTORY (Details) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - NOTE 3 - INVENTORY (Details) - Schedule of Inventory link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - NOTE 4 - DEBT (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - NOTE 5 - CAPITAL LEASE (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - NOTE 7 - STOCK AWARDS AND ISSUANCES (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - NOTE 8 - INCOME TAXES (Details) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - NOTE 9 - SUBSEQUENT EVENTS (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink XML 13 amty-20170331_htm.xml IDEA: XBRL DOCUMENT 0000945828 2017-03-31 0000945828 us-gaap:NotesPayableOtherPayablesMember 2016-07-01 2017-03-31 0000945828 us-gaap:NotesPayableOtherPayablesMember 2017-03-31 0000945828 us-gaap:NotesPayableOtherPayablesMember 2016-06-30 0000945828 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-01 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2017-03-31 0000945828 2015-07-31 0000945828 2016-06-30 0000945828 amty:OptionsGrantedDecember1_2015Member us-gaap:ChiefExecutiveOfficerMember 2015-12-01 2015-12-01 0000945828 amty:OptionsGrantedDecember1_2015Member us-gaap:ChiefExecutiveOfficerMember 2015-12-01 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMemberMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:AuditCommitteeChairMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMembersAndAuditoCommitteChairMember 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMembersAndAuditoCommitteChairMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:MinimumMember us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:MaximumMember us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 2017-01-01 2017-03-31 0000945828 us-gaap:ChiefExecutiveOfficerMember 2016-12-01 2016-12-01 0000945828 us-gaap:ChiefExecutiveOfficerMember 2016-12-01 0000945828 us-gaap:ChiefExecutiveOfficerMember 2016-07-01 2017-03-31 0000945828 us-gaap:ConvertibleDebtMember 2013-09-30 0000945828 us-gaap:ConvertibleDebtMember 2013-09-01 2013-09-30 0000945828 2015-07-01 2016-06-30 0000945828 amty:OptionsAt0.08Member 2017-03-31 0000945828 amty:OptionsAt0.08Member 2016-07-01 2017-03-31 0000945828 amty:OptionsAt0.10Member 2017-03-31 0000945828 amty:OptionsAt0.10Member 2016-07-01 2017-03-31 0000945828 2016-01-01 2016-03-31 0000945828 amty:OptionsAt017Member 2017-03-31 0000945828 amty:OptionsAt017Member 2016-07-01 2017-03-31 0000945828 2017-01-21 2017-01-21 0000945828 2017-01-21 0000945828 2017-01-31 2017-01-31 0000945828 amty:BoardMemberMember 2017-01-31 2017-01-31 0000945828 amty:BoardMembersAndAuditoCommitteChairMember 2017-01-31 2017-01-31 0000945828 2017-01-31 0000945828 us-gaap:ChiefExecutiveOfficerMember 2017-03-23 2017-03-23 0000945828 us-gaap:ChiefExecutiveOfficerMember 2017-02-22 0000945828 2016-07-01 2017-03-31 0000945828 2017-02-23 2017-02-23 0000945828 us-gaap:SubsequentEventMember 2017-04-30 0000945828 2015-07-01 2016-03-31 0000945828 2015-06-30 0000945828 2016-03-31 0000945828 2017-05-10 iso4217:USD iso4217:USD shares shares pure false 10-Q 2017-03-31 42647868 510807 267302 259378 293358 547194 614895 129761 103803 1447140 1279358 196223 153543 577549 577549 2988844 2960246 74921 74921 49732 10198 305924 305924 3906635 3849937 286558 232444 154906 175379 194066 180050 11000 11000 359972 366429 2093670 1878231 473752 348499 19141 20518 7285 6249 500178 375266 129111 100142 2792 8394 632081 483802 5000000 5000000 0.001 0.001 2000000 2000000 2000000 2000000 2000 2000 75000000 75000000 0.001 0.001 42647868 42647868 42175287 42175287 42647 42175 62604245 62579558 5047 4500 -61192350 -61233804 1461589 1394429 2093670 1878231 1133610 936612 2849370 2865433 693500 618366 1861288 2081813 440110 318246 988082 783620 54130 56839 163174 166406 65000 53639 191191 219898 170813 172270 510596 666910 289943 282748 864961 1053214 150167 35498 123121 -269594 1773 870 6837 2404 70 28 170 137 -1703 -842 -6667 -2267 148464 34656 116454 -271861 25000 25000 75000 75000 123464 9656 41454 -346861 0.00 0.00 0.00 -0.01 42382635 41951935 42336460 41770978 116454 -271861 77171 116338 0 -289 20706 56238 -33980 165609 -53685 -25318 83951 38339 55253 5731 273298 -272473 15187 0 -15187 0 4566 3322 10040 1603 0 75000 -14606 -79925 243505 -352398 267302 455717 510807 103319 6837 2404 0 0 0 19337 0 6312 0 7641 81224 0 95625 0 75000 0 4500 0 5000 0 <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  We believe the disclosures and information presented are adequate to make the information not misleading.  These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K.  Operating results for the nine months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2017.</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K, except as noted below.</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Reclassifications</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify">Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements to conform to the current presentation, specifically the separation of “store” inventory as part of other current assets at March 31, 2016.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">Basic and Fully Diluted Net Loss Per Share</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Basic and Fully Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Our outstanding stock options and warrants have been excluded from the basic and fully diluted net income per share calculation.  We excluded 4,280,000 and 4,300,000 common stock equivalents for the quarters ended March 31, 2017 and 2016, respectively, because they are anti-dilutive with strike prices above market value at period end.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left"> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">Recent Accounting Pronouncements</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><span style="text-decoration:underline">Recently Adopted and Recently Issued Accounting Guidance</span></div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><span style="text-decoration:underline">Issued</span></div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; ">In August 2016, the FASB issued ASU No. 2016-15, “<span style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (consensus of Emerging Issues Task Force)</span>”.  <span style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; ">This Accounting Standards Update addresses the following eight specific cash flow issues: Debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies (COLIs) (including bank-owned life insurance policies (BOLIs)); distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle.</span> ASU 2016-15 amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. For all other public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period.  The Company is currently assessing the impact, if any, to the Company’s financial statements.</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Reclassifications</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify">Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements to conform to the current presentation, specifically the separation of “store” inventory as part of other current assets at March 31, 2016.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">Basic and Fully Diluted Net Loss Per Share</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Basic and Fully Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Our outstanding stock options and warrants have been excluded from the basic and fully diluted net income per share calculation.  We excluded 4,280,000 and 4,300,000 common stock equivalents for the quarters ended March 31, 2017 and 2016, respectively, because they are anti-dilutive with strike prices above market value at period end.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left"> </div> 4280000 4300000 <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">Recent Accounting Pronouncements</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><span style="text-decoration:underline">Recently Adopted and Recently Issued Accounting Guidance</span></div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><span style="text-decoration:underline">Issued</span></div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; ">In August 2016, the FASB issued ASU No. 2016-15, “<span style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (consensus of Emerging Issues Task Force)</span>”.  <span style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; ">This Accounting Standards Update addresses the following eight specific cash flow issues: Debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies (COLIs) (including bank-owned life insurance policies (BOLIs)); distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle.</span> ASU 2016-15 amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. For all other public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period.  The Company is currently assessing the impact, if any, to the Company’s financial statements.</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 3 - INVENTORY</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div><table border="0" cellpadding="0" cellspacing="0" id="z93504ed68b184638ac18faa2270a529f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 75%; margin-left: auto; margin-right: auto;"> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 47%" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">March 31, 2017</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">June 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 47%" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(Unaudited)</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 47%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Raw Materials</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">216,436</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">257,260</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 47%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Finished Goods</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">570,441</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">663,666</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 47%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Inventory reserve</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">(45,617</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">)</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">(125,981</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">)</div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 47%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Inventory - net</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">741,260</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">794,945</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Our inventory reserve reflects items that were deemed to be defective or obsolete based on an analysis of all inventories on hand.</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">In fiscal years 2017 and 2016, the Company critically reviewed all slow moving inventory to determine if defective or obsolete.  If not defective or obsolete we presented these items as non-current inventory because all inventory is ready and available for sale at any moment.  </div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">For those items that are spare maintenance materials or parts kept on hand as backup components of major production equipment, or “store inventories”, the Company capitalizes the amount if above our capitalization policy for property and equipment.  In the past the Company included these items as part of its raw materials inventory.  As of March 31, 2016 these items, amounting to $10,815, have been reclassified into other current assets. </div> Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.<table border="0" cellpadding="0" cellspacing="0" id="z93504ed68b184638ac18faa2270a529f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 75%; margin-left: auto; margin-right: auto;"> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 47%" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">March 31, 2017</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">June 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 47%" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(Unaudited)</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 47%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Raw Materials</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">216,436</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">257,260</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 47%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Finished Goods</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">570,441</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">663,666</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 47%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Inventory reserve</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">(45,617</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">)</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">(125,981</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">)</div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 47%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Inventory - net</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">741,260</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">794,945</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> 216436 257260 570441 663666 45617 125981 741260 794945 10815 <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 4 - DEBT</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">A former board member, Silas O. Kines, who passed away on January 11, 2012, was also the principal owner of Forklift Tire of Florida and K-2 Industrial Tire, Inc.  In accordance with the Commission Agreement with Forklift Tire of Florida, dated February 2, 2011, between Amerityre Corporation and K-2 Industrial Tire, Inc., K-2 is due a five percent (5%) commission on all forklift tire sales.  In exchange for the forklift models transferred to Amerityre under that agreement, the first $96,000 in commission payments will be used to extinguish the long term liability recorded on the transaction.  As of March 31, 2017, $2,000 and $63,133 (June 30, 2016, $11,752 and $53,840) were recorded for the current and long-term portion, respectively, of the related liability.</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">In June 2016, the Company executed a term note with U.S. Bank to finance critical manufacturing equipment and operating enhancements.  Manufacturing equipment of approximately $29,000 was placed into service in July 2016.  The remaining operating enhancements are expected to be in service at the end of fiscal 2017.  Total amount financed was $55,068, at 5.59% interest, with payments of $1,059 due for 60 months starting July 2016.</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">In July 2016, the Company executed a term note with U.S. Bank to finance critical plant facility equipment which was placed into service in July 2016.  The total amount financed was $37,666 at 5.59% interest, with payments of $720 due for 60 months starting October 2016.</div><div> </div><table cellpadding="0" cellspacing="0" id="zb28e93d979f14f04b7005d2625054cba" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr style="HEIGHT: 25px"> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"/> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 13px" valign="bottom"/> <td colspan="18" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 1073px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Payments due by period</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr style="HEIGHT: 27px"> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 13px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 192px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Total</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Less than</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">1 year </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">1 to 3 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">3 to 5 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">After</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">5 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 13px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 192px" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Bank debt (both US Bank facilities above)</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1.21%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">83,119</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">17,141</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">59,726</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">6,252</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 30%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1.21%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt">Total cash obligations</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1.21%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">83,119</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">17,141</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">59,726</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">6,252</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 0.05 96000 2000 63133 11752 53840 29000 55068 0.0559 1059 P60M0D 37666 0.0559 720 P60M0D <table cellpadding="0" cellspacing="0" id="zb28e93d979f14f04b7005d2625054cba" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr style="HEIGHT: 25px"> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"/> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 13px" valign="bottom"/> <td colspan="18" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 1073px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Payments due by period</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr style="HEIGHT: 27px"> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 13px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 192px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Total</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Less than</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">1 year </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">1 to 3 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">3 to 5 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">After</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">5 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 13px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 192px" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Bank debt (both US Bank facilities above)</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1.21%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">83,119</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">17,141</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">59,726</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">6,252</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 30%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1.21%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt">Total cash obligations</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1.21%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">83,119</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">17,141</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">59,726</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">6,252</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 83119 17141 59726 6252 0 83119 17141 59726 6252 0 <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 5 - CAPITAL LEASE</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">In July 2015, the Company entered into a capital lease for research and development equipment for $19,337.</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of March 31, 2017:</div><div><br/> </div><table cellpadding="0" cellspacing="0" id="z21a5d1f3d60c4cd9a0730da5d60418c2" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">2017</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2,174</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">2018</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">8,697</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">2019</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">725</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">2020</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 86%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">2021</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">Total minimum lease payments</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">11,596</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 86%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">Less:  executory costs</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">Net minimum lease payments</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">11,596</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 86%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">Less:  amount representing interest</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">(1,533</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">)</div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 86%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">Present value of net minimum payments</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">10,063</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 19337 The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of March 31, 2017:<table cellpadding="0" cellspacing="0" id="z21a5d1f3d60c4cd9a0730da5d60418c2" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">2017</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2,174</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">2018</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">8,697</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">2019</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">725</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">2020</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 86%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">2021</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">Total minimum lease payments</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">11,596</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 86%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">Less:  executory costs</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 86%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">Net minimum lease payments</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">11,596</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 86%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">Less:  amount representing interest</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">(1,533</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">)</div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 86%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">Present value of net minimum payments</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">10,063</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 2174 8697 725 0 0 11596 0 11596 1533 10063 <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 6 - STOCK OPTIONS AND WARRANTS</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><span style="text-decoration:underline">Prior Issuances of options</span></div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">On December 1, 2015, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2016 and expire December 1, 2020.  </div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">On January 19, 2016, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the Board term ending December 2016.  The options have a strike price of $0.10, vest at the end of the Board term in December 2016 and expire December 2019.  </div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">On January 19, 2016, 50,000 options were granted to the Company’s Chief Financial Officer as part of renewal of her employment agreement.  The options have a strike price of $0.10, vest ratably January 21, 2016 to December 1, 2016 and expire December 1, 2019.  </div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><span style="text-decoration:underline">Option issuances and vesting during the nine month period ending March 31, 2017</span></div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">On December 1, 2016, 480,000 options were granted to the Company’s Chief Executive Officer as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2017 and expire December 1, 2020.  Year to date expense related to these options is $583 as of March 31, 2017. </div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">As of March 31, 2017, there was $ 1,021 of unrecognized stock-based compensation expense related to stock options that will be recognized over the vest period of the underlying option.</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">We estimated the fair value of the stock options granted in the current fiscal year above at the grant date based on the following weighted average assumptions:</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div><table cellpadding="0" cellspacing="0" id="z112806d2835c490fa5405c1dafa6ad24" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 61.31%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Risk free interest rate</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 22.17%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">1.450</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 11.85%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">% </div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 61.31%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Expected life</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 22.17%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">3.0</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 11.85%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> years </div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 61.31%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Expected volatility</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 22.17%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">126.36</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 11.85%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">% </div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 61.31%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Dividend yield</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 22.17%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 11.85%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">% </div> </td> </tr> </table><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center"> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Year to date expense related to these options is $15,660 as of March 31, 2017.</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">A summary of the status of our outstanding stock options as of March 31, 2017 and June 30, 2016, and changes during the periods then ended is presented below:</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">  </div><table cellpadding="0" cellspacing="0" id="z5a26c23e36df46eabe66f670e8d753cf" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;"> </div> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">March 31, 2017</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">June 30, 2016</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;"> </div> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Weight Average</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Intrinsic</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Weight Average</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Intrinsic</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;"> </div> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Shares</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercise Price</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Value</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Shares</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercise Price</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Value</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Outstanding beginning of period</div> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">3,800,000</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.13</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">2,270,000</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.14</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Granted</div> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">480,000</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.10</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">1,530,000</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.10</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Expired/Cancelled</div> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.00</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.00</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Exercised</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.00</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.00</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 4px; width: 16%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Outstanding end of period</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">4,280,000</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.12</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">3,800,000</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.13</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 4px; width: 16%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Exercisable</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">3,960,000</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.12</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">3,070,000</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.13</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table><p> </p><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">The following table summarizes the range of outstanding and exercisable options as of March 31, 2017:</div><div><br/> </div><table cellpadding="0" cellspacing="0" id="z1c16a5497e144e34a8376fc6615056b0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="10" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Outstanding</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="6" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Exercisable</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Range of</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Exercise Prices</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Number Outstanding</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">at</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">March 31, 2017</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Average</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Remaining</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Contractual Life</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Average</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Exercise Price</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Number</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Exercisable at</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">March 31, 2017</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Average Remaining</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Contractual Life</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.08</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">150,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">4.67</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.08</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">150,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">4.67</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.10</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2,680,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2.35</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.10</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2,360,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2.35</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">1,450,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">3.67</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">1,450,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">3.67</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">4,280,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">3,960,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">General Warrant Information</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">In September 2013, the Company obtained an extension on the remaining $100,000 secured convertible promissory note that was issued in the private placement that closed in September 2010.  This note was paid off as of June 30, 2015.   In exchange for the extension, the note holder received 500,000 common stock warrants and $6,500 in accrued interest and fees.  The common stock warrants expire three years from the date of issuance, are exercisable at $0.13 per share, and vest on the next date the value of Amerityre common stock reaches $0.25 per share.  As of September 30, 2016 the warrants expired.</div> 480000 0.10 2016-12-01 2020-12-01 100000 50000 0.10 December 2016 December 2019 50000 0.10 2016-01-21 2016-12-01 2019-12-01 480000 0.10 2017-12-01 2020-12-01 583 1021 We estimated the fair value of the stock options granted in the current fiscal year above at the grant date based on the following weighted average assumptions:<table cellpadding="0" cellspacing="0" id="z112806d2835c490fa5405c1dafa6ad24" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 61.31%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Risk free interest rate</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 22.17%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">1.450</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 11.85%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">% </div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 61.31%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Expected life</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 22.17%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">3.0</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 11.85%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> years </div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 61.31%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Expected volatility</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 22.17%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">126.36</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 11.85%; BACKGROUND-COLOR: #cceeff"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">% </div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 61.31%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Dividend yield</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 2.33%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 22.17%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: right">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 11.85%; "> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">% </div> </td> </tr> </table><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center"> </div> 0.01450 P3Y0M0D 1.2636 0.0000 15660 A summary of the status of our outstanding stock options as of March 31, 2017 and June 30, 2016, and changes during the periods then ended is presented below:<table cellpadding="0" cellspacing="0" id="z5a26c23e36df46eabe66f670e8d753cf" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;"> </div> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">March 31, 2017</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">June 30, 2016</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;"> </div> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Weight Average</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Intrinsic</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Weight Average</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Intrinsic</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;"> </div> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Shares</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercise Price</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Value</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Shares</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercise Price</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: #000000 2px solid;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000; text-align: center;">Value</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Outstanding beginning of period</div> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">3,800,000</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.13</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">2,270,000</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.14</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Granted</div> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">480,000</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.10</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">1,530,000</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.10</div> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Expired/Cancelled</div> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.00</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; text-align: right; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.00</div> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; text-align: left; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Exercised</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.00</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: right;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.00</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="vertical-align: bottom;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 4px; width: 16%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Outstanding end of period</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">4,280,000</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.12</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">3,800,000</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.13</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 4px; width: 16%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Exercisable</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">3,960,000</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.12</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">3,070,000</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">0.13</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 11%;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table><p> </p> 3800000 0.13 2270000 0.14 480000 0.10 1530000 0.10 0 0.00 0 0.00 0 0.00 0 0.00 4280000 0.12 0 3800000 0.13 0 3960000 0.12 0 3070000 0.13 0 The following table summarizes the range of outstanding and exercisable options as of March 31, 2017:<table cellpadding="0" cellspacing="0" id="z1c16a5497e144e34a8376fc6615056b0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="10" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Outstanding</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="6" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Exercisable</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Range of</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Exercise Prices</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Number Outstanding</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">at</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">March 31, 2017</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Average</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Remaining</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Contractual Life</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Average</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Exercise Price</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Number</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Exercisable at</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">March 31, 2017</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Average Remaining</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Contractual Life</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.08</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">150,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">4.67</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.08</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">150,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">4.67</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.10</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2,680,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2.35</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.10</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2,360,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2.35</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">1,450,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">3.67</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">0.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">1,450,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">3.67</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">4,280,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">3,960,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table><div><br/> </div> 0.08 150000 P4Y8M1D 0.08 150000 P4Y8M1D 0.10 2680000 P2Y4M6D 0.10 2360000 P2Y4M6D 0.17 1450000 P3Y8M1D 0.17 1450000 P3Y8M1D 4280000 3960000 100000 500000 6500 P3Y 0.13 0.25 <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 7 – STOCK AWARDS AND ISSUANCES</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">On January 21, 2017, 60,000 shares were granted to the Company’s Chief Financial Officer as part of her employment renewal.  The shares are valued as of January 20, 2017 ($0.04) and vest ratably through December 2017.</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">As of January 31, 2017, 225,000 shares were granted to the Company’s Board of Director’s as Board compensation for the term ending November 2017.  Each non-executive Board member receives 50,000 shares, with the Audit Committee Chair receiving 75,000 shares.  The shares vest ratably January – December 2017, valued at a fixed rate of $0.0155, the closing stock price on January 31, 2017.</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">On March 23, 2017, the Company’s Chief Executive Officer, finalized the negotiation of the replacement and extension of his employment contract.  While all material compensation terms were finalized February 23, 2017 other items within the agreement, filed via Form 8-k on March 27, 2017, were finalized as of March 23, 2017. The Agreement replaces the current employment agreement and extends his term of employment to December 31, 2018.  Inclusive in this new agreement is a stock award of 2.4 million shares of the Company’s common stock vesting ratably over twenty-three months (February 2017 – December 2018),  valued at a fixed rate of $0.0168, the closing stock price on February 22, 2017.</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">As all of the above awards may be issued once vested, the Company is accounting for the above in stock payable.  As of March 31, 2017 stock payable is $5,047.</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">On February 23, 2017 the Board of Director’s approved a partial payment of Mr. Sullivan’s 2016 bonus in stock.  This partial payment of $5,000 resulted in the issuance of 322,581 shares of stock.</div> 60000 0.04 225000 50000 75000 0.0155 2400000 P23M 0.0168 5047 5000 322581 <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 8 – INCOME TAXES</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">As of March 31, 2017 the Company has net income year to date.  As such, the Company is working with its tax professionals to utilize available net operating loss carryforwards.  Due to the difference between our taxed effected net income as of this period end and the net operating loss of approximately $17,300,000 as of June 30, 2016, the Company continues to apply a 100% valuation allowance on any remaining deferred tax asset.</div> 17300000 1 <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 9 - SUBSEQUENT EVENTS</div><div><br/> </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> In April 2017, the Board of Directors closed the Amerityre Corporation 2015 Omnibus Stock Option and Award Plan as all units under the plan had been expended.  Contemporaneous with this, the Board approved the Amerityre Corporation 2017 Omnibus Stock Option and Award Plan for a total of 3,000,000 shares of the Company’s common stock.</div> 3000000 Amerityre Corp --06-30 0000945828 Yes No Smaller Reporting Company No 2017 Q3 XML 14 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1
Document And Entity Information - shares
9 Months Ended
Mar. 31, 2017
May 10, 2017
Document and Entity Information [Abstract]    
Entity Registrant Name Amerityre Corp  
Document Type 10-Q  
Current Fiscal Year End Date --06-30  
Entity Common Stock, Shares Outstanding   42,647,868
Amendment Flag false  
Entity Central Index Key 0000945828  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Filer Category Smaller Reporting Company  
Entity Well-known Seasoned Issuer No  
Document Period End Date Mar. 31, 2017  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q3  
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Balance Sheets - USD ($)
Mar. 31, 2017
Jun. 30, 2016
CURRENT ASSETS    
Cash $ 510,807 $ 267,302
Accounts receivable 259,378 293,358
Inventory - net 547,194 614,895
Prepaid and other current assets 129,761 103,803
Total Current Assets 1,447,140 1,279,358
PROPERTY AND EQUIPMENT    
Leasehold improvements 196,223 153,543
Molds and models 577,549 577,549
Equipment 2,988,844 2,960,246
Furniture and fixtures 74,921 74,921
Construction in progress 49,732 10,198
Software 305,924 305,924
Less - accumulated depreciation (3,906,635) (3,849,937)
Total Property and Equipment 286,558 232,444
OTHER ASSETS    
Patents and trademarks - net 154,906 175,379
Non-current inventory 194,066 180,050
Deposits 11,000 11,000
Total Other Assets 359,972 366,429
TOTAL ASSETS 2,093,670 1,878,231
CURRENT LIABILITIES    
Accounts payable and accrued expenses 473,752 348,499
Current portion of long-term debt 19,141 20,518
Current portion of lease liability 7,285 6,249
Total Current Liabilities 500,178 375,266
Long-term debt 129,111 100,142
Long-term lease liability 2,792 8,394
TOTAL LIABILITIES 632,081 483,802
STOCKHOLDERS’ EQUITY    
Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively 2,000 2,000
Common stock: 75,000,000 shares authorized of $0.001 par value, 42,647,868 and 42,175,287 shares Issued and outstanding, respectively 42,647 42,175
Additional paid-in capital 62,604,245 62,579,558
Stock payable 5,047 4,500
Accumulated deficit (61,192,350) (61,233,804)
Total Stockholders’ Equity 1,461,589 1,394,429
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 2,093,670 $ 1,878,231
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
Balance Sheets (Parentheticals) - $ / shares
Mar. 31, 2017
Jun. 30, 2016
Preferred stock par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 2,000,000 2,000,000
Preferred stock, shares outstanding 2,000,000 2,000,000
Common stock par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 75,000,000 75,000,000
Common stock, shares issued 42,647,868 42,175,287
Common stock, shares outstanding 42,647,868 42,175,287
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
NET SALES $ 1,133,610 $ 936,612 $ 2,849,370 $ 2,865,433
COST OF GOODS SOLD 693,500 618,366 1,861,288 2,081,813
GROSS PROFIT 440,110 318,246 988,082 783,620
EXPENSES        
Research and development 54,130 56,839 163,174 166,406
Sales and marketing 65,000 53,639 191,191 219,898
General and administrative 170,813 172,270 510,596 666,910
Total Expenses 289,943 282,748 864,961 1,053,214
INCOME (LOSS) FROM OPERATIONS 150,167 35,498 123,121 (269,594)
OTHER INCOME/(EXPENSE)        
Interest expense (1,773) (870) (6,837) (2,404)
Interest income 70 28 170 137
Total Other Income/(Expense) (1,703) (842) (6,667) (2,267)
NET INCOME (LOSS) 148,464 34,656 116,454 (271,861)
Preferred Stock Dividend (25,000) (25,000) (75,000) (75,000)
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS $ 123,464 $ 9,656 $ 41,454 $ (346,861)
BASIC AND DILUTED INCOME (LOSS) PER SHARE (in Dollars per share) $ 0.00 $ 0.00 $ 0.00 $ (0.01)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in Shares) 42,382,635 41,951,935 42,336,460 41,770,978
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Mar. 31, 2017
Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) $ 116,454 $ (271,861)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:    
Depreciation and amortization expense 77,171 116,338
Change in allowance for bad debt (recovery) 0 (289)
Stock based compensation related to consultant, employee and director options 20,706 56,238
Changes in operating assets and liabilities:    
Accounts receivable 33,980 (165,609)
Inventory and inventory reserve 53,685 25,318
Prepaid and other current assets (83,951) (38,339)
Accounts payable and accrued expenses 55,253 5,731
Net Cash Provided (Used) by Operating Activities 273,298 (272,473)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of property and equipment (15,187) 0
Net Cash Used by Investing Activities (15,187) 0
CASH FLOWS FROM FINANCING ACTIVITIES    
Payments on lease liability (4,566) (3,322)
Payments on notes payable (10,040) (1,603)
Preferred stock dividends 0 (75,000)
Net Cash Used by Financing Activities (14,606) (79,925)
NET INCREASE (DECREASE) IN CASH 243,505 (352,398)
CASH AT BEGINNING OF PERIOD 267,302 455,717
CASH AT END OF PERIOD 510,807 103,319
SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES    
Interest paid 6,837 2,404
Income taxes paid 0 0
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Capitalized lease 0 19,337
Reclassification of accounts receivable – related party to accounts receivable 0 6,312
Equipment purchase accrued for, not paid in cash 0 7,641
Write off of previously reserved forklift tires 81,224 0
Purchase of fixed assets through debt 95,625 0
Accrued preferred stock dividends 75,000 0
Issuance of stock for stock payable 4,500 0
Issuance of stock for accrued expense $ 5,000 $ 0
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION
9 Months Ended
Mar. 31, 2017
Disclosure Text Block [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION
 
The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  We believe the disclosures and information presented are adequate to make the information not misleading.  These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K.  Operating results for the nine months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2017.
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Mar. 31, 2017
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K, except as noted below.

Reclassifications

Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements to conform to the current presentation, specifically the separation of “store” inventory as part of other current assets at March 31, 2016.
 
Basic and Fully Diluted Net Loss Per Share
 
Basic and Fully Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period.
 
Our outstanding stock options and warrants have been excluded from the basic and fully diluted net income per share calculation.  We excluded 4,280,000 and 4,300,000 common stock equivalents for the quarters ended March 31, 2017 and 2016, respectively, because they are anti-dilutive with strike prices above market value at period end.
 
Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Issued

In August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (consensus of Emerging Issues Task Force)”.  This Accounting Standards Update addresses the following eight specific cash flow issues: Debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies (COLIs) (including bank-owned life insurance policies (BOLIs)); distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle. ASU 2016-15 amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. For all other public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period.  The Company is currently assessing the impact, if any, to the Company’s financial statements.
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 3 - INVENTORY
9 Months Ended
Mar. 31, 2017
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]
NOTE 3 - INVENTORY

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.
 
 
 
March 31, 2017
   
June 30, 2016
 
 
 
(Unaudited)
       
Raw Materials
 
$
216,436
   
$
257,260
 
Finished Goods
   
570,441
     
663,666
 
Inventory reserve
   
(45,617
)
   
(125,981
)
Inventory - net
 
$
741,260
     
794,945
 
 
Our inventory reserve reflects items that were deemed to be defective or obsolete based on an analysis of all inventories on hand.

In fiscal years 2017 and 2016, the Company critically reviewed all slow moving inventory to determine if defective or obsolete.  If not defective or obsolete we presented these items as non-current inventory because all inventory is ready and available for sale at any moment.  

For those items that are spare maintenance materials or parts kept on hand as backup components of major production equipment, or “store inventories”, the Company capitalizes the amount if above our capitalization policy for property and equipment.  In the past the Company included these items as part of its raw materials inventory.  As of March 31, 2016 these items, amounting to $10,815, have been reclassified into other current assets. 
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 4 - DEBT
9 Months Ended
Mar. 31, 2017
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]
NOTE 4 - DEBT

A former board member, Silas O. Kines, who passed away on January 11, 2012, was also the principal owner of Forklift Tire of Florida and K-2 Industrial Tire, Inc.  In accordance with the Commission Agreement with Forklift Tire of Florida, dated February 2, 2011, between Amerityre Corporation and K-2 Industrial Tire, Inc., K-2 is due a five percent (5%) commission on all forklift tire sales.  In exchange for the forklift models transferred to Amerityre under that agreement, the first $96,000 in commission payments will be used to extinguish the long term liability recorded on the transaction.  As of March 31, 2017, $2,000 and $63,133 (June 30, 2016, $11,752 and $53,840) were recorded for the current and long-term portion, respectively, of the related liability.

In June 2016, the Company executed a term note with U.S. Bank to finance critical manufacturing equipment and operating enhancements.  Manufacturing equipment of approximately $29,000 was placed into service in July 2016.  The remaining operating enhancements are expected to be in service at the end of fiscal 2017.  Total amount financed was $55,068, at 5.59% interest, with payments of $1,059 due for 60 months starting July 2016.

In July 2016, the Company executed a term note with U.S. Bank to finance critical plant facility equipment which was placed into service in July 2016.  The total amount financed was $37,666 at 5.59% interest, with payments of $720 due for 60 months starting October 2016.
 
Payments due by period
 
   
Total
   
Less than
1 year
   
1 to 3 years
   
3 to 5 years
   
After
5 years
 
                               
Bank debt (both US Bank facilities above)
 
$
83,119
   
$
17,141
   
$
59,726
   
$
6,252
   
$
-
 
 
                                       
Total cash obligations
 
$
83,119
   
$
17,141
   
$
59,726
   
$
6,252
   
$
-
 
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 5 - CAPITAL LEASE
9 Months Ended
Mar. 31, 2017
Disclosure Text Block Supplement [Abstract]  
Debt and Capital Leases Disclosures [Text Block]
NOTE 5 - CAPITAL LEASE

In July 2015, the Company entered into a capital lease for research and development equipment for $19,337.

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of March 31, 2017:

2017
 
$
2,174
 
2018
   
8,697
 
2019
   
725
 
2020
   
-
 
2021
   
-
 
Total minimum lease payments
   
11,596
 
Less:  executory costs
   
-
 
Net minimum lease payments
   
11,596
 
Less:  amount representing interest
   
(1,533
)
Present value of net minimum payments
 
$
10,063
 
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 6 - STOCK OPTIONS AND WARRANTS
9 Months Ended
Mar. 31, 2017
Disclosure Text Block Supplement [Abstract]  
Shareholders' Equity and Share-based Payments [Text Block]
NOTE 6 - STOCK OPTIONS AND WARRANTS

Prior Issuances of options

On December 1, 2015, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2016 and expire December 1, 2020.  

On January 19, 2016, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the Board term ending December 2016.  The options have a strike price of $0.10, vest at the end of the Board term in December 2016 and expire December 2019.  

On January 19, 2016, 50,000 options were granted to the Company’s Chief Financial Officer as part of renewal of her employment agreement.  The options have a strike price of $0.10, vest ratably January 21, 2016 to December 1, 2016 and expire December 1, 2019.  

Option issuances and vesting during the nine month period ending March 31, 2017

On December 1, 2016, 480,000 options were granted to the Company’s Chief Executive Officer as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2017 and expire December 1, 2020.  Year to date expense related to these options is $583 as of March 31, 2017. 

As of March 31, 2017, there was $ 1,021 of unrecognized stock-based compensation expense related to stock options that will be recognized over the vest period of the underlying option.

We estimated the fair value of the stock options granted in the current fiscal year above at the grant date based on the following weighted average assumptions:
 
Risk free interest rate
 
 
1.450
Expected life
 
 
3.0
 years 
Expected volatility
 
 
126.36
Dividend yield
 
 
0.00
 
Year to date expense related to these options is $15,660 as of March 31, 2017.

A summary of the status of our outstanding stock options as of March 31, 2017 and June 30, 2016, and changes during the periods then ended is presented below:
  
 
 
March 31, 2017
   
June 30, 2016
 
 
       
Weight Average
 
Intrinsic
         
Weight Average
 
Intrinsic
 
 
 
Shares
   
Exercise Price
 
Value
   
Shares
   
Exercise Price
 
Value
 
Outstanding beginning of period
   
3,800,000
   
$
0.13
         
2,270,000
   
$
0.14
     
Granted
   
480,000
   
$
0.10
         
1,530,000
   
$
0.10
     
Expired/Cancelled
   
-
   
$
0.00
         
-
   
$
0.00
     
Exercised
   
-
   
$
0.00
         
-
   
$
0.00
     
Outstanding end of period
   
4,280,000
   
$
0.12
   
$
-
     
3,800,000
   
$
0.13
   
$
-
 
Exercisable
   
3,960,000
   
$
0.12
   
$
-
     
3,070,000
   
$
0.13
   
$
-
 

 

The following table summarizes the range of outstanding and exercisable options as of March 31, 2017:

     
Outstanding
   
Exercisable
 
Range of
Exercise Prices
   
Number Outstanding
at
March 31, 2017
   
Weighted
Average
Remaining
Contractual Life
   
Weighted
Average
Exercise Price
   
Number
Exercisable at
March 31, 2017
   
Weighted
Average Remaining
Contractual Life
 
$
0.08
     
150,000
     
4.67
   
$
0.08
     
150,000
     
4.67
 
$
0.10
     
2,680,000
     
2.35
   
$
0.10
     
2,360,000
     
2.35
 
$
0.17
     
1,450,000
     
3.67
   
$
0.17
     
1,450,000
     
3.67
 
         
4,280,000
                     
3,960,000
         

General Warrant Information

In September 2013, the Company obtained an extension on the remaining $100,000 secured convertible promissory note that was issued in the private placement that closed in September 2010.  This note was paid off as of June 30, 2015.   In exchange for the extension, the note holder received 500,000 common stock warrants and $6,500 in accrued interest and fees.  The common stock warrants expire three years from the date of issuance, are exercisable at $0.13 per share, and vest on the next date the value of Amerityre common stock reaches $0.25 per share.  As of September 30, 2016 the warrants expired.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 7 - STOCK AWARDS AND ISSUANCES
9 Months Ended
Mar. 31, 2017
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
NOTE 7 – STOCK AWARDS AND ISSUANCES

On January 21, 2017, 60,000 shares were granted to the Company’s Chief Financial Officer as part of her employment renewal.  The shares are valued as of January 20, 2017 ($0.04) and vest ratably through December 2017.

As of January 31, 2017, 225,000 shares were granted to the Company’s Board of Director’s as Board compensation for the term ending November 2017.  Each non-executive Board member receives 50,000 shares, with the Audit Committee Chair receiving 75,000 shares.  The shares vest ratably January – December 2017, valued at a fixed rate of $0.0155, the closing stock price on January 31, 2017.

On March 23, 2017, the Company’s Chief Executive Officer, finalized the negotiation of the replacement and extension of his employment contract.  While all material compensation terms were finalized February 23, 2017 other items within the agreement, filed via Form 8-k on March 27, 2017, were finalized as of March 23, 2017. The Agreement replaces the current employment agreement and extends his term of employment to December 31, 2018.  Inclusive in this new agreement is a stock award of 2.4 million shares of the Company’s common stock vesting ratably over twenty-three months (February 2017 – December 2018),  valued at a fixed rate of $0.0168, the closing stock price on February 22, 2017.

As all of the above awards may be issued once vested, the Company is accounting for the above in stock payable.  As of March 31, 2017 stock payable is $5,047.

On February 23, 2017 the Board of Director’s approved a partial payment of Mr. Sullivan’s 2016 bonus in stock.  This partial payment of $5,000 resulted in the issuance of 322,581 shares of stock.
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 8 - INCOME TAXES
9 Months Ended
Mar. 31, 2017
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
NOTE 8 – INCOME TAXES

As of March 31, 2017 the Company has net income year to date.  As such, the Company is working with its tax professionals to utilize available net operating loss carryforwards.  Due to the difference between our taxed effected net income as of this period end and the net operating loss of approximately $17,300,000 as of June 30, 2016, the Company continues to apply a 100% valuation allowance on any remaining deferred tax asset.
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 9 - SUBSEQUENT EVENTS
9 Months Ended
Mar. 31, 2017
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
NOTE 9 - SUBSEQUENT EVENTS

 In April 2017, the Board of Directors closed the Amerityre Corporation 2015 Omnibus Stock Option and Award Plan as all units under the plan had been expended.  Contemporaneous with this, the Board approved the Amerityre Corporation 2017 Omnibus Stock Option and Award Plan for a total of 3,000,000 shares of the Company’s common stock.
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Accounting Policies, by Policy (Policies)
9 Months Ended
Mar. 31, 2017
Accounting Policies [Abstract]  
Reclassification, Policy [Policy Text Block]
Reclassifications

Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements to conform to the current presentation, specifically the separation of “store” inventory as part of other current assets at March 31, 2016.
 
Earnings Per Share, Policy [Policy Text Block]
Basic and Fully Diluted Net Loss Per Share
 
Basic and Fully Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period.
 
Our outstanding stock options and warrants have been excluded from the basic and fully diluted net income per share calculation.  We excluded 4,280,000 and 4,300,000 common stock equivalents for the quarters ended March 31, 2017 and 2016, respectively, because they are anti-dilutive with strike prices above market value at period end.
 
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Issued

In August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (consensus of Emerging Issues Task Force)”.  This Accounting Standards Update addresses the following eight specific cash flow issues: Debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies (COLIs) (including bank-owned life insurance policies (BOLIs)); distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle. ASU 2016-15 amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. For all other public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period.  The Company is currently assessing the impact, if any, to the Company’s financial statements.
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 3 - INVENTORY (Tables)
9 Months Ended
Mar. 31, 2017
Inventory Disclosure [Abstract]  
Schedule of Inventory [Table Text Block] Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.
 
 
March 31, 2017
   
June 30, 2016
 
 
 
(Unaudited)
       
Raw Materials
 
$
216,436
   
$
257,260
 
Finished Goods
   
570,441
     
663,666
 
Inventory reserve
   
(45,617
)
   
(125,981
)
Inventory - net
 
$
741,260
     
794,945
 
 
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 4 - DEBT (Tables)
9 Months Ended
Mar. 31, 2017
Debt Disclosure [Abstract]  
Schedule of Maturities of Long-term Debt [Table Text Block]
Payments due by period
 
   
Total
   
Less than
1 year
   
1 to 3 years
   
3 to 5 years
   
After
5 years
 
                               
Bank debt (both US Bank facilities above)
 
$
83,119
   
$
17,141
   
$
59,726
   
$
6,252
   
$
-
 
 
                                       
Total cash obligations
 
$
83,119
   
$
17,141
   
$
59,726
   
$
6,252
   
$
-
 
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 5 - CAPITAL LEASE (Tables)
9 Months Ended
Mar. 31, 2017
Disclosure Text Block Supplement [Abstract]  
Schedule of Capital Leased Assets [Table Text Block] The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of March 31, 2017:
2017
 
$
2,174
 
2018
   
8,697
 
2019
   
725
 
2020
   
-
 
2021
   
-
 
Total minimum lease payments
   
11,596
 
Less:  executory costs
   
-
 
Net minimum lease payments
   
11,596
 
Less:  amount representing interest
   
(1,533
)
Present value of net minimum payments
 
$
10,063
 
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables)
9 Months Ended
Mar. 31, 2017
Disclosure Text Block Supplement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] We estimated the fair value of the stock options granted in the current fiscal year above at the grant date based on the following weighted average assumptions:
Risk free interest rate
 
 
1.450
Expected life
 
 
3.0
 years 
Expected volatility
 
 
126.36
Dividend yield
 
 
0.00
 
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] A summary of the status of our outstanding stock options as of March 31, 2017 and June 30, 2016, and changes during the periods then ended is presented below:
 
 
March 31, 2017
   
June 30, 2016
 
 
       
Weight Average
 
Intrinsic
         
Weight Average
 
Intrinsic
 
 
 
Shares
   
Exercise Price
 
Value
   
Shares
   
Exercise Price
 
Value
 
Outstanding beginning of period
   
3,800,000
   
$
0.13
         
2,270,000
   
$
0.14
     
Granted
   
480,000
   
$
0.10
         
1,530,000
   
$
0.10
     
Expired/Cancelled
   
-
   
$
0.00
         
-
   
$
0.00
     
Exercised
   
-
   
$
0.00
         
-
   
$
0.00
     
Outstanding end of period
   
4,280,000
   
$
0.12
   
$
-
     
3,800,000
   
$
0.13
   
$
-
 
Exercisable
   
3,960,000
   
$
0.12
   
$
-
     
3,070,000
   
$
0.13
   
$
-
 

 

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] The following table summarizes the range of outstanding and exercisable options as of March 31, 2017:
     
Outstanding
   
Exercisable
 
Range of
Exercise Prices
   
Number Outstanding
at
March 31, 2017
   
Weighted
Average
Remaining
Contractual Life
   
Weighted
Average
Exercise Price
   
Number
Exercisable at
March 31, 2017
   
Weighted
Average Remaining
Contractual Life
 
$
0.08
     
150,000
     
4.67
   
$
0.08
     
150,000
     
4.67
 
$
0.10
     
2,680,000
     
2.35
   
$
0.10
     
2,360,000
     
2.35
 
$
0.17
     
1,450,000
     
3.67
   
$
0.17
     
1,450,000
     
3.67
 
         
4,280,000
                     
3,960,000
         

XML 33 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - shares
9 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Accounting Policies [Abstract]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 4,280,000 4,300,000
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 3 - INVENTORY (Details)
9 Months Ended
Mar. 31, 2017
USD ($)
Inventory Disclosure [Abstract]  
Prior Period Reclassification Adjustment $ 10,815
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 3 - INVENTORY (Details) - Schedule of Inventory - USD ($)
Mar. 31, 2017
Jun. 30, 2016
Schedule of Inventory [Abstract]    
Raw Materials $ 216,436 $ 257,260
Finished Goods 570,441 663,666
Inventory reserve (45,617) (125,981)
Inventory - net $ 741,260 $ 794,945
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 4 - DEBT (Details) - USD ($)
1 Months Ended 9 Months Ended
Jul. 31, 2016
Jun. 30, 2016
Mar. 31, 2017
NOTE 4 - DEBT (Details) [Line Items]      
Long-term Debt, Current Maturities   $ 20,518 $ 19,141
Long-term Debt, Excluding Current Maturities   100,142 $ 129,111
Property, Plant and Equipment, Transfers and Changes $ 29,000    
Notes Payable, Other Payables [Member]      
NOTE 4 - DEBT (Details) [Line Items]      
Sales Commission, Percentage     5.00%
Debt Instrument, Face Amount     $ 96,000
Long-term Debt, Current Maturities   11,752 2,000
Long-term Debt, Excluding Current Maturities   53,840 $ 63,133
Notes Payable to Banks [Member]      
NOTE 4 - DEBT (Details) [Line Items]      
Debt Instrument, Face Amount $ 37,666 $ 55,068  
Debt Instrument, Interest Rate, Stated Percentage 5.59% 5.59%  
Debt Instrument, Periodic Payment $ 720 $ 1,059  
Debt Instrument, Term 60 months 60 months  
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt
Mar. 31, 2017
USD ($)
NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt [Line Items]  
Total $ 83,119
Less than 1 year 17,141
1 to 3 years 59,726
3 to 5 years 6,252
After 5 years 0
Notes Payable to Banks [Member]  
NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt [Line Items]  
Total 83,119
Less than 1 year 17,141
1 to 3 years 59,726
3 to 5 years 6,252
After 5 years $ 0
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 5 - CAPITAL LEASE (Details) - USD ($)
Mar. 31, 2017
Jul. 31, 2015
Disclosure Text Block Supplement [Abstract]    
Capital Leases, Future Minimum Payments Due $ 11,596 $ 19,337
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets - USD ($)
Mar. 31, 2017
Jul. 31, 2015
Schedule of Capital Leased Assets [Abstract]    
2017 $ 2,174  
2018 8,697  
2019 725  
2020 0  
2021 0  
Total minimum lease payments 11,596 $ 19,337
Less: executory costs 0  
Net minimum lease payments 11,596  
Less: amount representing interest (1,533)  
Present value of net minimum payments $ 10,063  
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Dec. 01, 2016
Jan. 19, 2016
Dec. 01, 2015
Sep. 30, 2013
Mar. 31, 2017
Mar. 31, 2016
Jun. 30, 2016
Feb. 22, 2017
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         480,000   1,530,000  
Allocated Share-based Compensation Expense         $ 15,660      
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options         1,021      
Interest Paid         6,837 $ 2,404    
Convertible Debt [Member]                
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                
Convertible Notes Payable, Current       $ 100,000        
Class of Warrant or Rights, Granted       500,000        
Interest Paid       $ 6,500        
Warrants, Term of Warrants       3 years        
Class of Warrant or Right, Exercise Price of Warrants or Rights       $ 0.13        
Share Price       $ 0.25        
Chief Executive Officer [Member]                
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 480,000              
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price $ 0.10              
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date Dec. 01, 2017              
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Dec. 01, 2020              
Allocated Share-based Compensation Expense         $ 583      
Share Price               $ 0.0168
Chief Executive Officer [Member] | Options Granted December 1, 2015 [Member]                
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     480,000          
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price     $ 0.10          
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date     Dec. 01, 2016          
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date     Dec. 01, 2020          
Board member [Member] | Options Granted January 19, 2016 [Member]                
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   100,000            
Audit Committee Chair [Member] | Options Granted January 19, 2016 [Member]                
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   50,000            
Board Members and Audito Committe Chair [Member] | Options Granted January 19, 2016 [Member]                
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price   $ 0.10            
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date   December 2016            
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date   December 2019            
Chief Financial Officer [Member] | Options Granted January 19, 2016 [Member]                
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   50,000            
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price   $ 0.10            
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date   Dec. 01, 2019            
Minimum [Member] | Chief Financial Officer [Member] | Options Granted January 19, 2016 [Member]                
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date   Jan. 21, 2016            
Maximum [Member] | Chief Financial Officer [Member] | Options Granted January 19, 2016 [Member]                
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date   Dec. 01, 2016            
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
9 Months Ended
Mar. 31, 2017
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Abstract]  
Risk free interest rate 1.45%
Expected life 3 years
Expected volatility 126.36%
Dividend yield 0.00%
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity - USD ($)
9 Months Ended 12 Months Ended
Mar. 31, 2017
Jun. 30, 2016
Schedule of Share-based Compensation, Stock Options, Activity [Abstract]    
Outstanding beginning of period 3,800,000 2,270,000
Outstanding beginning of period $ 0.13 $ 0.14
Granted 480,000 1,530,000
Granted $ 0.10 $ 0.10
Expired/Cancelled 0 0
Expired/Cancelled $ (0.00) $ (0.00)
Exercised 0 0
Exercised $ 0.00 $ 0.00
Outstanding end of period 4,280,000 3,800,000
Outstanding end of period $ 0.12 $ 0.13
Outstanding end of period $ 0 $ 0
Exercisable 3,960,000 3,070,000
Exercisable $ 0.12 $ 0.13
Exercisable $ 0 $ 0
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range - $ / shares
9 Months Ended
Mar. 31, 2017
Jun. 30, 2016
Jun. 30, 2015
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Number of Options Outstanding 4,280,000 3,800,000 2,270,000
Weighted Average Exercise Price of Outstanding Options (in Dollars per share) $ 0.12 $ 0.13 $ 0.14
Number of Exercisable Options 3,960,000 3,070,000  
Options at $0.08 [Member]      
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Exercise Price of Options (in Dollars per share) $ 0.08    
Number of Options Outstanding 150,000    
Weighted Average Remaining Contractual Life of Outstanding Options 4 years 8 months 1 day    
Weighted Average Exercise Price of Outstanding Options (in Dollars per share) $ 0.08    
Number of Exercisable Options 150,000    
Weighted Average Remaining Contractual Life of Exercisable Options 4 years 8 months 1 day    
Options at $0.10 [Member]      
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Exercise Price of Options (in Dollars per share) $ 0.10    
Number of Options Outstanding 2,680,000    
Weighted Average Remaining Contractual Life of Outstanding Options 2 years 4 months 6 days    
Weighted Average Exercise Price of Outstanding Options (in Dollars per share) $ 0.10    
Number of Exercisable Options 2,360,000    
Weighted Average Remaining Contractual Life of Exercisable Options 2 years 4 months 6 days    
Options at $0.17 [Member]      
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Exercise Price of Options (in Dollars per share) $ 0.17    
Number of Options Outstanding 1,450,000    
Weighted Average Remaining Contractual Life of Outstanding Options 3 years 8 months 1 day    
Weighted Average Exercise Price of Outstanding Options (in Dollars per share) $ 0.17    
Number of Exercisable Options 1,450,000    
Weighted Average Remaining Contractual Life of Exercisable Options 3 years 8 months 1 day    
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 7 - STOCK AWARDS AND ISSUANCES (Details) - USD ($)
Mar. 23, 2017
Feb. 23, 2017
Jan. 31, 2017
Jan. 21, 2017
Mar. 31, 2017
Feb. 22, 2017
Jun. 30, 2016
NOTE 7 - STOCK AWARDS AND ISSUANCES (Details) [Line Items]              
Stock Issued During Period, Shares, Share-based Compensation, Gross   322,581 225,000 60,000      
Shares Issued, Price Per Share (in Dollars per share)     $ 0.0155 $ 0.04      
Common Stock, Value, Subscriptions (in Dollars)         $ 5,047   $ 4,500
Stock Issued During Period, Value, Share-based Compensation, Gross (in Dollars)   $ 5,000          
Board member [Member]              
NOTE 7 - STOCK AWARDS AND ISSUANCES (Details) [Line Items]              
Stock Issued During Period, Shares, Share-based Compensation, Gross     50,000        
Board Members and Audito Committe Chair [Member]              
NOTE 7 - STOCK AWARDS AND ISSUANCES (Details) [Line Items]              
Stock Issued During Period, Shares, Share-based Compensation, Gross     75,000        
Chief Executive Officer [Member]              
NOTE 7 - STOCK AWARDS AND ISSUANCES (Details) [Line Items]              
Stock Issued During Period, Shares, Share-based Compensation, Gross 2,400,000            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 23 months            
Share Price (in Dollars per share)           $ 0.0168  
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 8 - INCOME TAXES (Details)
12 Months Ended
Jun. 30, 2016
USD ($)
Income Tax Disclosure [Abstract]  
Operating Loss Carryforwards $ 17,300,000
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent 100.00%
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTE 9 - SUBSEQUENT EVENTS (Details)
Apr. 30, 2017
shares
Subsequent Event [Member]  
NOTE 9 - SUBSEQUENT EVENTS (Details) [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 3,000,000
EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 51 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 51 176 1 false 16 0 false 4 false false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://www.amerityre.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Balance Sheets Sheet http://www.amerityre.com/role/ConsolidatedBalanceSheet Balance Sheets Statements 2 false false R3.htm 002 - Statement - Balance Sheets (Parentheticals) Sheet http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Statements of Operations (Unaudited) Sheet http://www.amerityre.com/role/ConsolidatedIncomeStatement Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Statements of Cash Flows (Unaudited) Sheet http://www.amerityre.com/role/ConsolidatedCashFlow Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Disclosure - NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION Sheet http://www.amerityre.com/role/NOTE1BASISOFFINANCIALSTATEMENTPRESENTATION NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION Notes 6 false false R7.htm 006 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 007 - Disclosure - NOTE 3 - INVENTORY Sheet http://www.amerityre.com/role/NOTE3INVENTORY NOTE 3 - INVENTORY Notes 8 false false R9.htm 008 - Disclosure - NOTE 4 - DEBT Sheet http://www.amerityre.com/role/NOTE4DEBT NOTE 4 - DEBT Notes 9 false false R10.htm 009 - Disclosure - NOTE 5 - CAPITAL LEASE Sheet http://www.amerityre.com/role/NOTE5CAPITALLEASE NOTE 5 - CAPITAL LEASE Notes 10 false false R11.htm 010 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS Sheet http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTS NOTE 6 - STOCK OPTIONS AND WARRANTS Notes 11 false false R12.htm 011 - Disclosure - NOTE 7 - STOCK AWARDS AND ISSUANCES Sheet http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCES NOTE 7 - STOCK AWARDS AND ISSUANCES Notes 12 false false R13.htm 012 - Disclosure - NOTE 8 - INCOME TAXES Sheet http://www.amerityre.com/role/NOTE8INCOMETAXES NOTE 8 - INCOME TAXES Notes 13 false false R14.htm 013 - Disclosure - NOTE 9 - SUBSEQUENT EVENTS Sheet http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTS NOTE 9 - SUBSEQUENT EVENTS Notes 14 false false R15.htm 014 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.amerityre.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies 15 false false R16.htm 015 - Disclosure - NOTE 3 - INVENTORY (Tables) Sheet http://www.amerityre.com/role/NOTE3INVENTORYTables NOTE 3 - INVENTORY (Tables) Tables http://www.amerityre.com/role/NOTE3INVENTORY 16 false false R17.htm 016 - Disclosure - NOTE 4 - DEBT (Tables) Sheet http://www.amerityre.com/role/NOTE4DEBTTables NOTE 4 - DEBT (Tables) Tables http://www.amerityre.com/role/NOTE4DEBT 17 false false R18.htm 017 - Disclosure - NOTE 5 - CAPITAL LEASE (Tables) Sheet http://www.amerityre.com/role/NOTE5CAPITALLEASETables NOTE 5 - CAPITAL LEASE (Tables) Tables http://www.amerityre.com/role/NOTE5CAPITALLEASE 18 false false R19.htm 018 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables) Sheet http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables) Tables http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTS 19 false false R20.htm 019 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 20 false false R21.htm 020 - Disclosure - NOTE 3 - INVENTORY (Details) Sheet http://www.amerityre.com/role/NOTE3INVENTORYDetails NOTE 3 - INVENTORY (Details) Details http://www.amerityre.com/role/NOTE3INVENTORYTables 21 false false R22.htm 021 - Disclosure - NOTE 3 - INVENTORY (Details) - Schedule of Inventory Sheet http://www.amerityre.com/role/ScheduleofInventoryTable NOTE 3 - INVENTORY (Details) - Schedule of Inventory Details http://www.amerityre.com/role/NOTE3INVENTORYTables 22 false false R23.htm 022 - Disclosure - NOTE 4 - DEBT (Details) Sheet http://www.amerityre.com/role/NOTE4DEBTDetails NOTE 4 - DEBT (Details) Details http://www.amerityre.com/role/NOTE4DEBTTables 23 false false R24.htm 023 - Disclosure - NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt Sheet http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt Details http://www.amerityre.com/role/NOTE4DEBTTables 24 false false R25.htm 024 - Disclosure - NOTE 5 - CAPITAL LEASE (Details) Sheet http://www.amerityre.com/role/NOTE5CAPITALLEASEDetails NOTE 5 - CAPITAL LEASE (Details) Details http://www.amerityre.com/role/NOTE5CAPITALLEASETables 25 false false R26.htm 025 - Disclosure - NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets Sheet http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets Details http://www.amerityre.com/role/NOTE5CAPITALLEASETables 26 false false R27.htm 026 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) Sheet http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) Details http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables 27 false false R28.htm 027 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Sheet http://www.amerityre.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Details http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables 28 false false R29.htm 028 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity Sheet http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity Details http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables 29 false false R30.htm 029 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range Sheet http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range Details http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables 30 false false R31.htm 030 - Disclosure - NOTE 7 - STOCK AWARDS AND ISSUANCES (Details) Sheet http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails NOTE 7 - STOCK AWARDS AND ISSUANCES (Details) Details http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCES 31 false false R32.htm 031 - Disclosure - NOTE 8 - INCOME TAXES (Details) Sheet http://www.amerityre.com/role/NOTE8INCOMETAXESDetails NOTE 8 - INCOME TAXES (Details) Details http://www.amerityre.com/role/NOTE8INCOMETAXES 32 false false R33.htm 032 - Disclosure - NOTE 9 - SUBSEQUENT EVENTS (Details) Sheet http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTSDetails NOTE 9 - SUBSEQUENT EVENTS (Details) Details http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTS 33 false false All Reports Book All Reports amty-20170331.htm amty-20170331.xsd amty-20170331_cal.xml amty-20170331_def.xml amty-20170331_lab.xml amty-20170331_pre.xml ex10-2.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm true true JSON 53 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "amty-20170331.htm": { "axisCustom": 0, "axisStandard": 6, "contextCount": 51, "dts": { "calculationLink": { "local": [ "amty-20170331_cal.xml" ] }, "definitionLink": { "local": [ "amty-20170331_def.xml" ] }, "inline": { "local": [ "amty-20170331.htm" ] }, "labelLink": { "local": [ "amty-20170331_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-doc-2016-01-31.xml", "http://xbrl.sec.gov/dei/2014/dei-doc-2014-01-31.xml" ] }, "presentationLink": { "local": [ "amty-20170331_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-ref-2016-01-31.xml", "http://xbrl.sec.gov/dei/2014/dei-ref-2014-01-31.xml" ] }, "schema": { "local": [ "amty-20170331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2016/elts/us-parts-codification-2016-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2016/elts/us-roles-2016-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd", "http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" ] } }, "elementCount": 257, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2014-01-31": 9, "total": 9 }, "keyCustom": 8, "keyStandard": 168, "memberCustom": 8, "memberStandard": 8, "nsprefix": "amty", "nsuri": "http://www.amerityre.com/20170331", "report": { "R1": { "firstAnchor": { "ancestors": [ "dei:AmendmentFlag", "div", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "true", "longName": "000 - Disclosure - Document And Entity Information", "role": "http://www.amerityre.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "dei:AmendmentFlag", "div", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - NOTE 5 - CAPITAL LEASE", "role": "http://www.amerityre.com/role/NOTE5CAPITALLEASE", "shortName": "NOTE 5 - CAPITAL LEASE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS", "role": "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTS", "shortName": "NOTE 6 - STOCK OPTIONS AND WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - NOTE 7 - STOCK AWARDS AND ISSUANCES", "role": "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCES", "shortName": "NOTE 7 - STOCK AWARDS AND ISSUANCES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - NOTE 8 - INCOME TAXES", "role": "http://www.amerityre.com/role/NOTE8INCOMETAXES", "shortName": "NOTE 8 - INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - NOTE 9 - SUBSEQUENT EVENTS", "role": "http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTS", "shortName": "NOTE 9 - SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PriorPeriodReclassificationAdjustmentDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://www.amerityre.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PriorPeriodReclassificationAdjustmentDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "amty:ScheduleOfInventoryTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - NOTE 3 - INVENTORY (Tables)", "role": "http://www.amerityre.com/role/NOTE3INVENTORYTables", "shortName": "NOTE 3 - INVENTORY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "amty:ScheduleOfInventoryTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - NOTE 4 - DEBT (Tables)", "role": "http://www.amerityre.com/role/NOTE4DEBTTables", "shortName": "NOTE 4 - DEBT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCapitalLeasedAsssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - NOTE 5 - CAPITAL LEASE (Tables)", "role": "http://www.amerityre.com/role/NOTE5CAPITALLEASETables", "shortName": "NOTE 5 - CAPITAL LEASE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCapitalLeasedAsssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables)", "role": "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables", "shortName": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Balance Sheets", "role": "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "shortName": "Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "0", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "role": "http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PriorPeriodReclassificationAdjustment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - NOTE 3 - INVENTORY (Details)", "role": "http://www.amerityre.com/role/NOTE3INVENTORYDetails", "shortName": "NOTE 3 - INVENTORY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PriorPeriodReclassificationAdjustment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - NOTE 3 - INVENTORY (Details) - Schedule of Inventory", "role": "http://www.amerityre.com/role/ScheduleofInventoryTable", "shortName": "NOTE 3 - INVENTORY (Details) - Schedule of Inventory", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "c1_AsOf30Jun2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - NOTE 4 - DEBT (Details)", "role": "http://www.amerityre.com/role/NOTE4DEBTDetails", "shortName": "NOTE 4 - DEBT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c12_From1Jul2016To31Jul2016", "decimals": "0", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentTransfersAndChanges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt", "role": "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable", "shortName": "NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalLeasesFutureMinimumPaymentsDue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - NOTE 5 - CAPITAL LEASE (Details)", "role": "http://www.amerityre.com/role/NOTE5CAPITALLEASEDetails", "shortName": "NOTE 5 - CAPITAL LEASE (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R26": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets", "role": "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable", "shortName": "NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details)", "role": "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "shortName": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": "0", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": "5", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions", "role": "http://www.amerityre.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable", "shortName": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": "5", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c1_AsOf30Jun2016", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity", "role": "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable", "shortName": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": "2", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Balance Sheets (Parentheticals)", "role": "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c0_AsOf31Mar2017", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range", "role": "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable", "shortName": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "c35_AsOf31Mar2017_OptionsAt0.08Member", "decimals": "2", "lang": null, "name": "amty:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisePrice", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c49_From23Feb2017To23Feb2017", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - NOTE 7 - STOCK AWARDS AND ISSUANCES (Details)", "role": "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails", "shortName": "NOTE 7 - STOCK AWARDS AND ISSUANCES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c49_From23Feb2017To23Feb2017", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c1_AsOf30Jun2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - NOTE 8 - INCOME TAXES (Details)", "role": "http://www.amerityre.com/role/NOTE8INCOMETAXESDetails", "shortName": "NOTE 8 - INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c1_AsOf30Jun2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c50_AsOf30Apr2017_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - NOTE 9 - SUBSEQUENT EVENTS (Details)", "role": "http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTSDetails", "shortName": "NOTE 9 - SUBSEQUENT EVENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "contextRef": "c50_AsOf30Apr2017_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "c2_From1Jan2017To31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SalesRevenueNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Statements of Operations (Unaudited)", "role": "http://www.amerityre.com/role/ConsolidatedIncomeStatement", "shortName": "Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "c2_From1Jan2017To31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SalesRevenueNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Statements of Cash Flows (Unaudited)", "role": "http://www.amerityre.com/role/ConsolidatedCashFlow", "shortName": "Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "005 - Disclosure - NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION", "role": "http://www.amerityre.com/role/NOTE1BASISOFFINANCIALSTATEMENTPRESENTATION", "shortName": "NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - NOTE 3 - INVENTORY", "role": "http://www.amerityre.com/role/NOTE3INVENTORY", "shortName": "NOTE 3 - INVENTORY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - NOTE 4 - DEBT", "role": "http://www.amerityre.com/role/NOTE4DEBT", "shortName": "NOTE 4 - DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "contextRef": "c4_From1Jul2016To31Mar2017", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 16, "tag": { "amty_AuditCommitteeChairMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information about related party.", "label": "Audit Committee Chair [Member]", "terseLabel": "Audit Committee Chair [Member]" } } }, "localname": "AuditCommitteeChairMember", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "amty_BoardMemberMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information about related parties.", "label": "Board Member [Member]", "terseLabel": "Board member [Member]" } } }, "localname": "BoardMemberMember", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "domainItemType" }, "amty_BoardMembersAndAuditoCommitteChairMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information related to board members and audit committee chair.", "label": "Board Members And Audito Committe Chair [Member]", "terseLabel": "Board Members and Audito Committe Chair [Member]" } } }, "localname": "BoardMembersAndAuditoCommitteChairMember", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "domainItemType" }, "amty_ClassOfWarrantOrRightsGranted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Aggregate amount of each class of warrants or rights granted.", "label": "Class of Warrant or Rights, Granted" } } }, "localname": "ClassOfWarrantOrRightsGranted", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "sharesItemType" }, "amty_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.amerityre.com/20170331", "xbrltype": "stringItemType" }, "amty_NOTE4DEBTDetailsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 4 - DEBT (Details) [Line Items]" } } }, "localname": "NOTE4DEBTDetailsLineItems", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "stringItemType" }, "amty_NOTE4DEBTDetailsScheduleofMaturitiesofLongtermDebtLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt [Line Items]" } } }, "localname": "NOTE4DEBTDetailsScheduleofMaturitiesofLongtermDebtLineItems", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "stringItemType" }, "amty_NOTE4DEBTDetailsScheduleofMaturitiesofLongtermDebtTable": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt [Table]" } } }, "localname": "NOTE4DEBTDetailsScheduleofMaturitiesofLongtermDebtTable", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "stringItemType" }, "amty_NOTE4DEBTDetailsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 4 - DEBT (Details) [Table]" } } }, "localname": "NOTE4DEBTDetailsTable", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "stringItemType" }, "amty_NOTE6STOCKOPTIONSANDWARRANTSDetailsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]" } } }, "localname": "NOTE6STOCKOPTIONSANDWARRANTSDetailsLineItems", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "amty_NOTE6STOCKOPTIONSANDWARRANTSDetailsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Table]" } } }, "localname": "NOTE6STOCKOPTIONSANDWARRANTSDetailsTable", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "amty_NOTE7STOCKAWARDSANDISSUANCESDetailsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 7 - STOCK AWARDS AND ISSUANCES (Details) [Line Items]" } } }, "localname": "NOTE7STOCKAWARDSANDISSUANCESDetailsLineItems", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "stringItemType" }, "amty_NOTE7STOCKAWARDSANDISSUANCESDetailsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 7 - STOCK AWARDS AND ISSUANCES (Details) [Table]" } } }, "localname": "NOTE7STOCKAWARDSANDISSUANCESDetailsTable", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "stringItemType" }, "amty_NOTE9SUBSEQUENTEVENTSDetailsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 9 - SUBSEQUENT EVENTS (Details) [Line Items]" } } }, "localname": "NOTE9SUBSEQUENTEVENTSDetailsLineItems", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "amty_NOTE9SUBSEQUENTEVENTSDetailsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 9 - SUBSEQUENT EVENTS (Details) [Table]" } } }, "localname": "NOTE9SUBSEQUENTEVENTSDetailsTable", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "amty_OptionsAt0.08Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of equity transaction.", "label": "Options At 0. 08 [Member]", "terseLabel": "Options at $0.08 [Member]" } } }, "localname": "OptionsAt0.08Member", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "domainItemType" }, "amty_OptionsAt0.10Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of equity transaction.", "label": "Options At 0. 10 [Member]", "terseLabel": "Options at $0.10 [Member]" } } }, "localname": "OptionsAt0.10Member", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "domainItemType" }, "amty_OptionsAt017Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of equity transaction.", "label": "Options At 017 [Member]", "terseLabel": "Options at $0.17 [Member]" } } }, "localname": "OptionsAt017Member", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "domainItemType" }, "amty_OptionsGrantedDecember1_2015Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Award date.", "label": "Options Granted December 1_ 2015 [Member]", "terseLabel": "Options Granted December 1, 2015 [Member]" } } }, "localname": "OptionsGrantedDecember1_2015Member", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "amty_OptionsGrantedJanuary19_2016Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Award date.", "label": "Options Granted January 19_ 2016 [Member]", "terseLabel": "Options Granted January 19, 2016 [Member]" } } }, "localname": "OptionsGrantedJanuary19_2016Member", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "amty_SalesCommissionPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of sales commission outlined in commission agreement.", "label": "Sales Commission, Percentage" } } }, "localname": "SalesCommissionPercentage", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "percentItemType" }, "amty_ScheduleOfCapitalLeasedAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Capital Leased Assets [Abstract]" } } }, "localname": "ScheduleOfCapitalLeasedAssetsAbstract", "nsuri": "http://www.amerityre.com/20170331", "xbrltype": "stringItemType" }, "amty_ScheduleOfInventoryAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Inventory [Abstract]" } } }, "localname": "ScheduleOfInventoryAbstract", "nsuri": "http://www.amerityre.com/20170331", "xbrltype": "stringItemType" }, "amty_ScheduleOfInventoryTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of inventory, current and noncurrent.", "label": "Schedule of Inventory [Table Text Block]" } } }, "localname": "ScheduleOfInventoryTableTextBlock", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE3INVENTORYTables" ], "xbrltype": "textBlockItemType" }, "amty_ScheduleOfMaturitiesOfLongTermDebtAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Maturities of Long-term Debt [Abstract]" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtAbstract", "nsuri": "http://www.amerityre.com/20170331", "xbrltype": "stringItemType" }, "amty_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Abstract]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAbstract", "nsuri": "http://www.amerityre.com/20170331", "xbrltype": "stringItemType" }, "amty_ScheduleOfShareBasedCompensationStockOptionsActivityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Share-based Compensation, Stock Options, Activity [Abstract]" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityAbstract", "nsuri": "http://www.amerityre.com/20170331", "xbrltype": "stringItemType" }, "amty_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Abstract]" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract", "nsuri": "http://www.amerityre.com/20170331", "xbrltype": "stringItemType" }, "amty_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The exercise price of the options granted.", "label": "Exercise Price of Options (in Dollars per share)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisePrice", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "perShareItemType" }, "amty_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date the equity-based award vest, in CCYY-MM-DD format.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "dateItemType" }, "amty_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationDate2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date the equity-based award expires.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationDate2", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationDate2", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "amty_SharebasedCompensationArrangementBySharebasedPaymentAwardVestingDate2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date the equity-based award vest.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardVestingDate2", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardVestingDate2", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "amty_WarrantsTermOfWarrants": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Term of warrants exercisable in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Warrants, Term of Warrants" } } }, "localname": "WarrantsTermOfWarrants", "nsuri": "http://www.amerityre.com/20170331", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "durationItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "If the value is true, then the document is an amendment to previously-filed/accepted document.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word \"Other\".", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r182" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate \"Yes\" or \"No\" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityFilerCategory": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r182" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate \"Yes\" or \"No\" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate \"Yes\" or \"No\" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r27", "r33" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r37", "r100" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less - accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r28" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r116", "r135", "r138" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.", "label": "Allocated Share-based Compensation Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the allowance for doubtful accounts.", "label": "Allowance for Doubtful Accounts Receivable, Period Increase (Decrease)", "terseLabel": "Change in allowance for bad debt (recovery)" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r0", "r3", "r4", "r89" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r167", "r174" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r17", "r18", "r51" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r117", "r136" ], "lang": { "en-US": { "role": { "documentation": "Information by date or year of grant, pertaining to equity-based compensation arrangements.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r117", "r136" ], "lang": { "en-US": { "role": { "documentation": "Date or year of grant of equity-based compensation.", "label": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalLeaseObligationsCurrent": { "auth_ref": [ "r23", "r154", "r156" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer.", "label": "Current portion of lease liability" } } }, "localname": "CapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeaseObligationsIncurred": { "auth_ref": [ "r72", "r73" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase during the period in capital lease obligations due to entering into new capital leases.", "label": "Capitalized lease" } } }, "localname": "CapitalLeaseObligationsIncurred", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeaseObligationsNoncurrent": { "auth_ref": [ "r45", "r154", "r156" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.", "label": "Long-term lease liability" } } }, "localname": "CapitalLeaseObligationsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r156" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 1.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases.", "label": "Capital Leases, Future Minimum Payments Due", "totalLabel": "Total minimum lease payments" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE5CAPITALLEASEDetails", "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r156" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2021" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r156" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 4.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2020" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r156" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 3.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2019" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r156" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 2.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2018" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsExecutoryCosts": { "auth_ref": [ "r156" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 2.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amounts to be paid by lessee to lessor for maintenance, insurance, and tax expenses related to the leased asset.", "label": "Less: executory costs" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsExecutoryCosts", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments": { "auth_ref": [ "r156" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 2.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount necessary to reduce net minimum lease payments to present value for capital leases.", "label": "Capital Leases, Future Minimum Payments, Interest Included in Payments", "negatedLabel": "Less: amount representing interest" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1": { "auth_ref": [ "r156" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 1.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases net of executory costs, which include amounts paid by the lessee to the lessor for insurance, maintenance and taxes.", "label": "Capital Leases, Future Minimum Payments, Net Minimum Payments", "totalLabel": "Net minimum lease payments" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments": { "auth_ref": [ "r156" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of minimum lease payments for capital leases net of executory costs, including amounts paid by the lessee to the lessor for insurance, maintenance and taxes.", "label": "Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "totalLabel": "Present value of net minimum payments" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 1.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2017" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [ "r180" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.", "label": "Software" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r1", "r2", "r15", "r36", "r70" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "periodEndLabel": "CASH AT END OF PERIOD", "periodStartLabel": "CASH AT BEGINNING OF PERIOD" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [ "r62", "r149" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease)", "totalLabel": "NET INCREASE (DECREASE) IN CASH" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChiefExecutiveOfficerMember": { "auth_ref": [ "r161" ], "lang": { "en-US": { "role": { "documentation": "Highest ranking executive officer, who has ultimate managerial responsibility for the entity and who reports to the board of directors. In addition, the chief executive officer (CEO) may also be the chairman of the board or president.", "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ChiefFinancialOfficerMember": { "auth_ref": [ "r161" ], "lang": { "en-US": { "role": { "documentation": "Senior executive officer responsible for overseeing the financial activities of the entity.", "label": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r83" ], "lang": { "en-US": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r26" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r26" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r26" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r26", "r108" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscriptions": { "auth_ref": [ "r26", "r106" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Stock payable", "terseLabel": "Common Stock, Value, Subscriptions (in Dollars)" } } }, "localname": "CommonStockSharesSubscriptions", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r26" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock: 75,000,000 shares authorized of $0.001 par value, 42,647,868 and 42,175,287 shares Issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConstructionInProgressGross": { "auth_ref": [ "r99" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in progress" } } }, "localname": "ConstructionInProgressGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r105" ], "lang": { "en-US": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Current" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r55" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "COST OF GOODS SOLD" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.", "label": "Debt and Capital Leases Disclosures [Text Block]" } } }, "localname": "DebtAndCapitalLeasesDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE5CAPITALLEASE" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r72", "r74" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Issuance of stock for accrued expense" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r40", "r109" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBT" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r151", "r153" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r44" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r45", "r173" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Debt Instrument, Periodic Payment" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DepositsAssetsNoncurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.", "label": "Deposits" } } }, "localname": "DepositsAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r68" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Disclosure Text Block [Abstract]" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisclosureTextBlockSupplementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Disclosure Text Block Supplement [Abstract]" } } }, "localname": "DisclosureTextBlockSupplementAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r113", "r172" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Accrued preferred stock dividends" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStockCash": { "auth_ref": [ "r113", "r172" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.", "label": "Dividends, Preferred Stock, Cash", "negatedLabel": "Preferred Stock Dividend" } } }, "localname": "DividendsPreferredStockCash", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "BASIC AND DILUTED INCOME (LOSS) PER SHARE (in Dollars per share)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r77", "r89", "r90", "r91" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r140", "r141", "r147" ], "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE8INCOMETAXESDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Unrecognized cost of unvested options awarded to employees as compensation.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfAssetsAcquired": { "auth_ref": [ "r72", "r73", "r74" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The fair value of assets acquired in noncash investing or financing activities.", "label": "Equipment purchase accrued for, not paid in cash" } } }, "localname": "FairValueOfAssetsAcquired", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesGross": { "auth_ref": [ "r99" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and fixtures" } } }, "localname": "FurnitureAndFixturesGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r56" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r54" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "GROSS PROFIT" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r82", "r142", "r143", "r145", "r146" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE8INCOMETAXES" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r64", "r71" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r67" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r67" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r67" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory and inventory reserve" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r67" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r97", "r98" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Patents and trademarks - net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r150", "r152", "r171" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r63", "r71" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid for interest during the period.", "label": "Interest paid", "terseLabel": "Interest Paid" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r20", "r50" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE3INVENTORY" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r46" ], "calculation": { "http://www.amerityre.com/role/ScheduleofInventoryTable": { "order": 2.0, "parentTag": "us-gaap_OtherInventoryNetOfReserves", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished Goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r16", "r48", "r95" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory - net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNoncurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.", "label": "Non-current inventory" } } }, "localname": "InventoryNoncurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r47" ], "calculation": { "http://www.amerityre.com/role/ScheduleofInventoryTable": { "order": 1.0, "parentTag": "us-gaap_OtherInventoryNetOfReserves", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw Materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r48", "r85", "r95", "r96" ], "calculation": { "http://www.amerityre.com/role/ScheduleofInventoryTable": { "order": 3.0, "parentTag": "us-gaap_OtherInventoryNetOfReserves", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Inventory reserve" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r57" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r68" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Stock based compensation related to consultant, employee and director options" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsGross": { "auth_ref": [ "r19", "r99" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.", "label": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r41" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r32", "r169", "r177" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r24", "r168", "r175" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Current portion of long-term debt", "terseLabel": "Long-term Debt, Current Maturities" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturingInYearsFourAndFive": { "auth_ref": [ "r103" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth and fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "3 to 5 years" } } }, "localname": "LongTermDebtMaturingInYearsFourAndFive", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturingInYearsTwoAndThree": { "auth_ref": [ "r103" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second and third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "1 to 3 years" } } }, "localname": "LongTermDebtMaturingInYearsTwoAndThree", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r84", "r103" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "After 5 years" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r84", "r103" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Less than 1 year" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r45" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term debt", "terseLabel": "Long-term Debt, Excluding Current Maturities" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r45" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails", "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r45", "r104" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails", "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r19", "r99" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Equipment" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r62", "r66" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Used by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r62", "r66" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used by Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r62", "r65", "r69" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Provided (Used) by Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r8", "r9", "r52", "r69", "r90", "r170", "r179" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income (loss)", "totalLabel": "NET INCOME (LOSS)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r86" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r58" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other Income/(Expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "OTHER INCOME/(EXPENSE)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_NotesIssued1": { "auth_ref": [ "r72", "r73", "r74" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value of notes issued in noncash investing and financing activities.", "label": "Purchase of fixed assets through debt" } } }, "localname": "NotesIssued1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableOtherPayablesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A written promise to pay a note to a third party.", "label": "Notes Payable, Other Payables [Member]" } } }, "localname": "NotesPayableOtherPayablesMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotesPayableToBanksMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A written promise to pay a note to a bank.", "label": "Notes Payable to Banks [Member]" } } }, "localname": "NotesPayableToBanksMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails", "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "INCOME (LOSS) FROM OPERATIONS" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r144" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE8INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r13", "r14", "r77", "r92", "r148" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE1BASISOFFINANCIALSTATEMENTPRESENTATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "OTHER ASSETS" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "totalLabel": "Total Other Assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInventoryNetOfReserves": { "auth_ref": [ "r50", "r96" ], "calculation": { "http://www.amerityre.com/role/ScheduleofInventoryTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after of valuation reserves and allowances, of inventory, classified as other, expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Other Inventory, Net of Reserves", "totalLabel": "Inventory - net" } } }, "localname": "OtherInventoryNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1": { "auth_ref": [ "r72", "r73", "r74" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.", "label": "Reclassification of accounts receivable \u2013 related party to accounts receivable" } } }, "localname": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1": { "auth_ref": [ "r72", "r73", "r74" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The value of the noncash (or part noncash) consideration received in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.", "label": "Write off of previously reserved forklift tires" } } }, "localname": "OtherSignificantNoncashTransactionValueOfConsiderationReceived1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r5", "r60" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Preferred stock dividends" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r6", "r59" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r25" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r25" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r25" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r25" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r25" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r17", "r34", "r35" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of a reclassification adjustment made to prior period financial statement amounts.", "label": "Prior Period Reclassification Adjustment" } } }, "localname": "PriorPeriodReclassificationAdjustment", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE3INVENTORYDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.", "label": "Reclassification, Policy [Policy Text Block]" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r21", "r22", "r101", "r178" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Total Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentNetAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentOther": { "auth_ref": [ "r101" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Molds and models" } } }, "localname": "PropertyPlantAndEquipmentOther", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTransfersAndChanges": { "auth_ref": [ "r102" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Transfers and Changes" } } }, "localname": "PropertyPlantAndEquipmentTransfersAndChanges", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by range, including, but not limited to, upper and lower bounds.", "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extent of variation, for example, but not limited to, upper and lower bounds.", "label": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r7", "r11", "r12", "r157", "r158", "r159" ], "lang": { "en-US": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r160", "r162", "r163", "r164", "r165" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfConvertibleDebt": { "auth_ref": [ "r5", "r61" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Repayments of Convertible Debt", "negatedLabel": "Payments on notes payable" } } }, "localname": "RepaymentsOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermCapitalLeaseObligations": { "auth_ref": [ "r61" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).", "label": "Repayments of Long-term Capital Lease Obligations", "negatedLabel": "Payments on lease liability" } } }, "localname": "RepaymentsOfLongTermCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r139", "r181" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r29", "r113", "r176" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNet": { "auth_ref": [ "r53" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.", "label": "NET SALES" } } }, "localname": "SalesRevenueNet", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Any scenario, that is, the particular reporting scenario is left unspecified. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures." } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfCapitalLeasedAsssetsTableTextBlock": { "auth_ref": [ "r155" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of long-lived, depreciable assets that are subject to a lease meeting the criteria for capitalization and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Schedule of Capital Leased Assets [Table Text Block]" } } }, "localname": "ScheduleOfCapitalLeasedAsssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE5CAPITALLEASETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r103" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r136" ], "lang": { "en-US": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r136" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r121" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.", "label": "Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r129" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r118" ], "lang": { "en-US": { "role": { "documentation": "Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "auth_ref": [ "r119" ], "lang": { "en-US": { "role": { "documentation": "Date the equity-based award expires, in CCYY-MM-DD format.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r131" ], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r133" ], "lang": { "en-US": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r120" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTSDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Number of Exercisable Options", "periodEndLabel": "Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable", "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r126" ], "lang": { "en-US": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Expired/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r126" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "negatedTerseLabel": "Expired/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Granted", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r136" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Outstanding end of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r123", "r136" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Number of Options Outstanding", "periodEndLabel": "Outstanding end of period", "periodStartLabel": "Outstanding beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable", "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r122" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Weighted Average Exercise Price of Outstanding Options (in Dollars per share)", "periodEndLabel": "Outstanding end of period", "periodStartLabel": "Outstanding beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable", "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r128" ], "lang": { "en-US": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r134" ], "lang": { "en-US": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share Price (in Dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r130", "r137" ], "lang": { "en-US": { "role": { "documentation": "Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Expected life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedPaymentAwardStockOptionsValuationAssumptionsTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r136" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r136" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Life of Exercisable Options" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r127" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Life of Outstanding Options" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "durationItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details.", "label": "Shareholders' Equity and Share-based Payments [Text Block]" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share (in Dollars per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r75", "r76", "r77", "r78", "r79" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementScenarioAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by scenario to be reported. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures.", "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r72", "r73", "r74" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Issuance of stock for stock payable" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.", "label": "Stock Issued During Period, Shares, Share-based Compensation, Gross" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r25", "r26", "r108", "r113", "r125" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Gross value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.", "label": "Stock Issued During Period, Value, Share-based Compensation, Gross (in Dollars)" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r26", "r30", "r31", "r93" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r10", "r26", "r30", "r31", "r80", "r81", "r94", "r107", "r108", "r109", "r110", "r111", "r112", "r113", "r114", "r115" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE7STOCKAWARDSANDISSUANCES" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r166" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r166" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE9SUBSEQUENTEVENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NON-CASH INVESTING AND FINANCING ACTIVITIES" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r87", "r88" ], "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in Shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Glossary": "Antidilution", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6505113" }, "r1": { "Glossary": "Cash", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6506951" }, "r10": { "Glossary": "Preferred Stock", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6521494" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=64862545&loc=d3e2921-110230" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=28183637&loc=d3e4852-112606" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644" }, "r11": { "Glossary": "Principal Owners", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6521851" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r12": { "Glossary": "Related Parties", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=16382449" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=35735333&loc=d3e288-107754" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65882285&loc=d3e32718-109319" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65882285&loc=d3e32559-109319" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65882285&loc=d3e32559-109319" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=64809438&loc=d3e5614-111684" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=64930785&loc=d3e28555-108399" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737" }, "r157": { "Glossary": "Affiliate", "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6504562" }, "r158": { "Glossary": "Control", "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6508935" }, "r159": { "Glossary": "Immediate Family", "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6515043" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r182": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12b", "Subsection": "1" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765" }, "r2": { "Glossary": "Cash Equivalents", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6507016" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r3": { "Glossary": "Contingent Stock Agreement", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6508534" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r4": { "Glossary": "Diluted Earnings Per Share", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6510752" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20,22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(d))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r5": { "Glossary": "Financing Activities", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6513228" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585" }, "r6": { "Glossary": "Investing Activities", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6516133" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3574-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585" }, "r7": { "Glossary": "Management", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6517382" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3044-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=68058157&loc=d3e18726-107790" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=68058157&loc=d3e18743-107790" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=68058157&loc=d3e18854-107790" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=68058157&loc=d3e18861-107790" }, "r8": { "Glossary": "Net Income", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=51831255" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(i)(4))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=64863997&loc=d3e1377-109256" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=64863997&loc=d3e1505-109256" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r9": { "Glossary": "Other Comprehensive Income", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=51831270" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" } }, "version": "2.0" } ZIP 54 0001185185-17-001071-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001185185-17-001071-xbrl.zip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end